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The publication of reports on
the health of populations is a long and
highly valued tradition in the annals of
public health. From the time of the recognition of
the role of public health action in the elimination of
certain infectious diseases, and the consequent
improvement in health status of the population, periodic
reports on the state of public health have been a feature of
health service administration.
As part of its developing and changing role, the Department
and its agencies are committed to the widest possible level
of consultation and communication on health and health-
related matters with its partners in the health system,
including the general population. In this context, and
as part of this exercise, it has been decided to
produce a report periodically from the office
of the Chief Medical Officer.
Introduction
The general purpose of the Report is:
• To make a contribution to the debate on issues relevant to the
development of public health policy
• To describe aspects of the health status of the Irish people by
reference to certain indicators of mortality and lifestyle
• To identify particular factors which are relevant to the major disease
entities affecting the Irish population
• To identify a specific theme of particular contemporary relevance to
health in Ireland.
While the Report will attempt to be comprehensive in dealing with the
issues identified above, such is the complexity of modern health systems
that it would not be possible to address in a single Report, many of the
issues and problems confronting the health service. In addition, in
publishing this Report, cognisance is taken of the fact that many agencies
and organisations in the health sector publish annual reports on their
activities and the impact of these activities on the state of public health.
Health boards produce public health reports which detail much of the
health and disease experience of their populations; statutory officers such
as the Inspector of Mental Hospitals and executive agencies such as the
Food Safety Authority of Ireland, the Irish Medicines Board, the Blood
Transfusion Service Board and the National Cancer Registry give details in
their annual reports of their activities in support of public health. In
addition, the Central Statistics Office provides information on deaths and
causes of death.
It is not, therefore, proposed to replicate these Reports or their contents, 
or to concentrate on issues relating to the funding, activity or micro-
management of health services, except in so far as they impinge upon 
the larger public health issues which will be the central focus of this and
future reports.
Health inequalities is the theme of this first Report. It begins with a chapter
on health information which makes a number of recommendations
relating to the data required to evaluate developments within the health
sector. In addition, the Report includes a review of the current situation
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and developments regarding infectious diseases and the three major causes
of premature mortality, namely cardiovascular disease, cancer, and
accidents. This provides a basis for a further review of these important
issues in subsequent reports.
Overview
As we approach the end of the twentieth century, Ireland can look back on
the last number of decades of solid achievement in improving the health
status of its population and providing health and personal social services
which, in terms of quality and comprehensiveness, compare very
favourably with services provided in other countries. It is clear, however,
that much still needs to be done in both these areas.
The early to middle decades of this century were characterised by the
widespread incidence of damaging and potentially lethal infectious
diseases such as polio, whooping cough, diphtheria and tuberculosis.
These diseases were gradually brought under control with the
improvement in environmental conditions through better housing and
cleaner water supply, along with better nutrition and particularly the
introduction of immunisation. Emphasis then passed on to other chronic
diseases. It is interesting, however, to note that in more recent times,
infectious diseases have become a major source of public concern and the
advent of HIV, the recrudescence in the western world of tuberculosis, and
the growing problems of antibiotic resistance in general have again
brought infectious diseases to the fore. 
With the establishment of a large measure of control over infectious
diseases in the 1940s, 1950s and 1960s, priorities evolved and changed.
Greater emphasis was placed on the access of individuals to doctors and
this saw the change from the old dispensary system to the concept of
choice of doctor as exemplified in the General Medical Service (GMS). The
hospital system began to be modernised and developed; the provision of
care for specific groups such as the elderly, children and the mentally ill,
was promoted and strategies for the integration of services were brought
forward and implemented. In recent years, more attention has been given
to the delivery of efficient health care, value for money and equity in
resource allocation. The 1994 Government Health Strategy, Shaping a
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healthier future (1994), sought to re-orientate the health services towards
the achievement of health and social gain for individuals, families, groups,
and the population as a whole, with particular emphasis on health
promotion and disease prevention.
As we look forward from the vantage point of the last year of the millennium,
those charged with responsibility for promoting and maintaining the health
of the population face a very complex and challenging environment. The
major challenges to be faced include the following:
• Responding in an appropriate fashion to the growing awareness and
level of expectation among the public in general about issues relating
to public health and the demand for high quality patient services
• Identifying and implementing the most appropriate strategies to help
promote and protect the health of the population by way of an
integrated approach across all sectors
• Developing indicators to evaluate and assess the effectiveness of
health care in all its forms, with particular reference to the utilisation
of emerging medical technology
• Developing structures and capacity to properly analyse and develop
policies in relation to the major bio-ethical issues confronting us as a
result of scientific progress
• Dealing with the problem of utilising the finite resources for health
services in an equitable, cost effective and efficient manner
• Recognising what people can expect from the services in terms of
outcome and quality of care, and supporting and nurturing a focus 
on quality
• Identifying, developing and training high quality managers and profes-
sionals to work in an increasingly complex and difficult environment.
In the context of challenges facing health and health services, this initial
report of the Chief Medical Officer (CMO) would wish to draw attention
to an issue which above all others is central to our understanding of the
experience of our population’s health and ill-health, namely the question
of health inequality.
4 I n t r o d u c t i o n
International research has demonstrated that those whose level of
economic prosperity is less than that of the wider community in which
they live, suffer a disproportionate burden of ill-health and premature
death when compared to the community as a whole and, in particular, to
those sections of the community who enjoy greater economic prosperity.
The identification and understanding of the factors which determine this
experience, and the development of strategies and plans to deal with these
inequalities, are arguably the most pressing priorities facing us in the
health field. The multi-dimensional nature of health and ill-health points
inexorably to the fact that the solution to what presents as health problems
lies in the wider community and that, while the health services have a part
to play in our response to this issue, health service provision must be
viewed as only one element within a broader context which recognises the
role of multiple influences and participants.
It is hoped that by identifying this reality and presenting it for
consideration, even in a general way in this, the first CMO’s report, an
informed, wide-ranging debate can be carried out on a most fundamental
issue facing our community.
Investment for Health
The various definitions of health which have been developed over the
years have focused on the notion of health as a positive concept rather
than merely the absence of disease. Health is now regarded as a resource
to be protected and developed so as to enable people to attain their
maximum physical and mental capacity. 
This then raises the immediate question of how we can utilise the political,
intellectual, personnel, and economic resources available to us as a
community in order to make the greatest possible impact in the area of
health. At the general level of discourse on health and health matters,
particularly in the media, the debate tends to revolve around issues such
as the length of waiting lists, or whether more or fewer patients are seen
for the amount of money expended. It is essentially a debate about the
efficient provision of acute medical services or the systematic control of
the consumption of these services.
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However, many authorities would contend that the contribution of
medical care to the health of a population is of less importance than the
impact of such factors as socio-economic circumstances, living conditions,
and access to and utilisation of educational services. A reasonable
inference from such a claim is that, in focusing the debate on this topic in
the way we do, we are in fact ignoring more fundamental and long-term
issues of how to create the conditions for the promotion of long-term
health and well being in our community. This is not to suggest that acute
services are not important; they are, of course, and their availability,
accessibility and quality are an indispensable element of civilised living as
we approach the twenty-first century.
The argument to be made here revolves, not so much around the efficiency
and effectiveness of the services provided in the curative sector, but on
how we develop the concept of health as a fundamental human resource
to be promoted and protected and, therefore, as something to be invested
in. It requires us to consider health as being inextricably linked to social
and economic progress. Health is at once a product of, and a necessary
condition for, economic development and, therefore, should be a central
consideration in any plan for social and economic development. If health
is to be considered a critical social resource, then strategies which help to
promote and protect health can be regarded as investment strategies. They
can be seen to maintain and support health in an equitable fashion. 
Accepting the concept of health as a social and economic resource poses a
significant challenge to our community. The following are some steps that
need to be taken if we are to meet such a challenge:
• Developing an understanding, at all levels in our society, of the real
and demonstrable determinants of the health of our population
• Placing the promotion of health and, in particular, the narrowing of
inequalities of health experience between differing segments of our
population, at the centre of all our efforts at social and economic
development
• Developing the technical capacity to identify and invest in the most
productive strategies
• There are many factors which influence health such as biological, the
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physical and social environment, personal lifestyle and health
services. Consequently, improvements in health status and reduction
in health inequalities can only be achieved by committed multi-
sectoral collaboration.
Finally, although an argument for investment in health as an aid to
continued economic development is a sound one, it is merely a secondary
and supporting argument in that the accomplishment of longevity and
significant health improvements, particularly for those most deprived, has
an intrinsic human value which does not easily lend itself to further
economic evaluation.
7I n t r o d u c t i o n

The World Health Organisation
(WHO) defines health as ‘a state of
complete physical, mental and social well-
being, not merely the absence of disease or
infirmity’. This is a very positive concept of health, but
does not automatically produce measures by which
health at a population level can be described.
Inevitably the measurement of population health is largely
reliant on the use of health indicators, most of which are
derived from mortality statistics. This provides a somewhat
limited picture of ill-health in a community as it only tells
us about conditions that are fatal, whereas a great deal of
ill-health is caused by non-fatal disease.
We lack a considerable amount of the information
required to give a full picture of the health and
illness of a population.
Health
1
General Facts and Figures
The development of a comprehensive population health surveillance
system would not only permit a more complete evaluation of population
health, but would also facilitate an assessment of population health
needs and the adequacy with which these needs are met by the health
services provided. The development of such a system is discussed at the
end of this chapter.
The population of Ireland
It is important to look at background demographic changes when
examining our current and future health situation. Different age groups
have different health profiles and health care requirements.
The population of Ireland has been increasing gradually over the past 50
years (Figure 1.1). Ireland had a very high birth rate from 1950 until the
early 1980s. However, this was largely offset by net emigration from the
country for several decades. The trend has been reversed in recent years
which have seen large numbers of immigrants in the younger age groups
coming into the country. At the last census, in 1996, the population stood
at just over 3.6 million.
There was a marked decline in the number of births per annum during the
1980s and the early 1990s (Figure 1.2). This had obvious consequences for
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Fig 1.1: Population trends in Ireland 1950-1996
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maternity and paediatric services. Since 1996 there has been a reversal of this
trend, but the number of births is still far less than was seen in the 1970s.
Ireland has a relatively young population. In comparison with the EU
average, Ireland has more children and adolescents and a lower proportion
of older adults (Figure 1.3).
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Fig 1.2: Births, Numbers and Rates 1950-1998
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Fig 1.3: Population age profiles in 5-year age groups: Ireland and EU
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Ageing in Europe is recognised as having significant implications for
health and health services. Older age groups have a higher prevalence of
chronic disease and a higher requirement for health service provision.
Population projections have been made for Ireland up to the year 2031,
based on assumptions regarding fertility, mortality and migration patterns
(Figure 1.4). These projections have been revised recently in the light of
significant changes in birth rate and immigration patterns. It is difficult to
predict, with any certainty, changes in younger age groups. Overall, the
population structure is predicted to become more mature, similar to the
current EU pattern, with relatively fewer in the younger age groups and an
expansion in the middle and older age groups. A striking increase in the
number of people over the age of 65 years is projected, particularly those
in the very old population (over 80 years). This is expected to pose a
significant challenge to our health and social services.
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Fig 1.4: Age profiles: Actual population 1996 and projected population
in 2031 for different assumptions
S
ou
rc
e:
 P
op
u
la
ti
on
 a
n
d 
L
ab
ou
r 
F
or
ce
 P
ro
je
ct
io
n
s 
2
0
0
1
-2
0
3
1
, 
C
S
O
Trends in mortality and life expectancy
Despite the fact that there have been considerable improvements in the
health of the Irish population over the past 50 years, population health
indicators in Ireland still compare very poorly with those of our European
neighbours.
Mortality
There has been a steady reduction in mortality rates in Ireland over the
past 50 years (Figure 1.5). There has also been considerable change in the
main causes of mortality over that time. In 1950 heart disease, strokes and
cancers were the main causes of death, as they are today. Other conditions
such as ‘senility’ and tuberculosis were also recorded as major causes.
There was considerable mortality from a number of infectious diseases
including tuberculosis, influenza, whooping cough, measles, polio,
typhoid fever, and scarlet fever. Over 90 maternal deaths were recorded.
Infant and childhood mortality rates were much higher than in the present
day. By contrast, in 1998 the main causes of death were chronic conditions
such as heart disease, strokes and cancers (Figure 1.6).
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Although Irish mortality rates have been falling, they are still high in
European terms. Mortality rates for females are lower than for males. The
age-standardised death rates for both males and females in Ireland are
higher than the European Union average (Figure 1.7 and Figure 1.8).
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Fig 1.7: Trends in age-standardised death rates, Males, 1970-1995: Ireland & EU
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Fig 1.6: Deaths by principal causes, Percentage distribution
1998
1950
Source: CSO
41.8%  Circulatory Diseases
23.7%  Cancer
15.1%  Respiratory Diseases
7.6%  Respiratory Diseases
4.9%  Injury and Poisoning
2.3%  Injury and Poisoning
6.3%  TB
1.1% Other Infectious Diseases
12.5%  Senility 27.2%  Other Causes
.61%  Infectious Diseases
13.2%  Other Causes
31.7%  Circulatory Diseases
11.2%  Cancer
Within Ireland, mortality rates vary significantly between health boards.
The development of the Public Health Information System (PHIS) by the
Information Management Unit in the Department of Health and Children
has facilitated further investigation of these differences at health board and
county level in recent years.
Life expectancy
As mortality rates have dropped, life expectancy in Ireland has increased
substantially. Table 1.1 shows changes in life expectancy in Ireland over
the latter half of the century. From 1950 to 1995, life expectancy at birth
for men increased by 8.5 years and for women by 11.5 years. Much of the
improvement in life expectancy at birth arises from better health and social
provision for infants and young children. The increase in life expectancy
achieved in older age groups is relatively small, particularly for males.
Over the same period, there was an increase in life expectancy of just two
years for males aged 60 whereas the equivalent figure for females was 4.7
years. However, Irish life expectancy is still below that for most other
countries in the EU (Fgure 1.9 and Figure 1.10). In 1995, Ireland had the
lowest life expectancy of all 15 countries at age 65 for both women and men.
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Fig 1.8: Trends in age-standardised death rates, Females, 1970-1995: Ireland & EU
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Table 1.1: Life expectancy in Ireland at selected ages for the period 1950-1995
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Male
1950-52 1960-62 1970-72 1980-82 1990-92 1993* 1994* 1995*
Life Expectancy
at age 0 64.5 68.1 68.8 70.1 72.3 72.6 73.2 73
Age 40 31.3 32.4 32.1 32.6 43.4 34.5 35.1 35
Age 65 12.1 12.6 12.4 12.6 13.4 13.4 13.9 13.7
Age 75 6.8 7.1 7.3 7.3 7.8 7.9 8.2 8.1
Female
1950-52 1960-62 1970-72 1980-82 1990-92 1993* 1994* 1995*
Life Expectancy
at age 0 67.1 71.9 73.5 75.6 77.9 78.1 78.7 78.6
Age 40 33.3 35.3 36 37.3 39.2 39.3 39.7 39.8
Age 65 13.3 14.4 15 15.7 17.1 17 17.4 17.4
Age 75 7.6 8.1 8.5 9.1 10.2 10.1 10.4 10.4
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Infant and maternal mortality 
Infant mortality rates have fallen steadily over the past 30 years and are
close to the EU average (Figure 1.11). Maternal mortality rates have also
shown dramatic improvement and maternal mortality figures are now very
low (Figure 1.12).
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Fig 1.11: Trends in infant mortality rates, 1970-1996: ireland and EU
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Fig 1.12: Trends in maternal mortality rates, 1970-1996: Ireland and EU
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Premature mortality
Ireland has a high rate of premature mortality, i.e. mortality aged under
65 years, when compared with our EU neighbours (Figure 1.13 and
Figure 1.14).
Approximately one-fifth of all deaths in Ireland are in people aged under
65 years of age. Much of this mortality is preventable. Cancer,
cardiovascular disease and accidents account for the majority of these
deaths (Figure 1.15). Shaping a healthier future (1994) identified these
three areas as requiring special attention if we are to achieve our national
objective of moving over a period of time to the higher levels of life
expectancy which are enjoyed by our European neighbours.
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Fig 1.13: Trends in age-standardised death rates, males, 0-64 years,
1970-1995: Ireland and EU
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Fig 1.14: Trends in age-standardised death rates, females, 0-64 years,
1970-1995: Ireland and EU
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Determinants of health
A high proportion of the mortality and morbidity suffered by the
population of Ireland is caused by chronic diseases such as cardiovascular
disease, chronic respiratory disease and cancer. While genetic or familial
factors play a significant role in the aetiology of these conditions,
modifiable risk factors such as smoking, diet and exercise habits are also
extremely important causes. We are largely reliant on surveys to obtain
information about these determinants of health in the general population. 
National health and lifestyle surveys
Two national baseline surveys of health-related behaviours among adults
and school-going young people were commissioned by the Department of
Health and Children in 1998 and carried out by the Centre for Health
Promotion Studies, National University of Ireland, Galway. These were the
SLÁN (Survey of Lifestyle, Attitudes and Nutrition) survey of adults aged
over 18 years and the HBSC (Health Behaviours in School-aged Children)
survey of children aged 9-17 years. 
The objective of the surveys was to provide a nationally representative
profile of population health status and behaviour as part of a needs
assessment process for the Department of Health and Children. It is
intended to conduct SLÁN on a 4-yearly cycle to allow monitoring of
trends in health and lifestyle behaviours. This first cycle was aimed at
Fig 1.15: Premature deaths by principal causes, percentage distribution 1998
Source: CSO
32.9%  Cancer
16.7%  Injury and Poisoning
24%  Other Causes
23.3%  Circulatory Diseases
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providing baseline information on general health, exercise, tobacco,
alcohol, other substances, accidents, and food and nutrition. Detailed
mental health assessment and cardiovascular risk factors including blood
pressure, cholesterol and body mass index were measured on a sub-sample
of the target adult population.
Preliminary analyses of the SLÁN and HBSC datasets were made around
the health targets as specified in Shaping a healthier future (1994). The
main findings were as follows:
General health
Overall, 48 per cent of SLÁN respondents reported excellent or very good
general health, though smokers were significantly less likely to do so.
Significantly more people in social classes 1-2 rated their health as
excellent. Regardless of age, gender and social class, ‘less stress’ was
perceived as the top priority for individuals bettering their health.
Smoking
Cigarettes are the single most important cause of avoidable ill-health. It is
estimated that smoking is responsible for about 30 per cent of all cancer
deaths, 20 per cent of deaths from coronary heart disease and stroke and
80 per cent of cases of chronic obstructive respiratory disease. Fifty per
cent of smokers will eventually die of tobacco-related disease and, of these,
about half will die in middle age. About 7,000 deaths in Ireland each year
can be attributed to smoking.
Males
Age group (yrs) SC1-2 SC3-4 SC5-6
18-34 33 42 41
35-54 22 33 36
55 plus 17 24 35
Total 25 36 37
Females
Age group (yrs) SC1-2 SC3-4 SC5-6
18-34 36 42 45
35-54 22 34 38
55 plus 17 19 19
Total 28 36 38
Table 1.2: Smoking prevalence (%) by gender, age and social class
The SLÁN findings regarding smoking are disturbing. Smoking rates among
adults far exceed the target of 20 per cent anticipated for the year 2000.
Overall 31 per cent of respondents reported being regular or occasional
cigarette smokers. Rates among younger women are now comparable with
men, at around 40 per cent. Most smokers reported that they wanted to
quit, perceived lack of willpower as the problem, and tended to rate their
health less well than non-smokers. There is a strong social class gradient
evident in national smoking patterns, as shown in Table 1.2.
The high number of children and teenagers who reported regular tobacco
use is of particular concern (Table 1.3). This pattern is being observed in
several developed countries. It is evident that repeated anti-smoking
campaigns over recent years have not had the desired impact on young
people. More forceful anti-tobacco measures, such as have been proposed
in the cardiovascular strategy, are urgently required.
Alcohol
There has been a shift in patterns of drinking in Ireland. Most adults now
drink alcohol. Twenty-seven per cent of males and 21 per cent of females
consume more than the recommended weekly limits of sensible alcohol
consumption (Table 1.4).
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Males
Age group (yrs) SC1-2 SC3-4 SC5-6
9-11 7 13 6
12-14 20 18 20
15-17 31 33 28
Females
Age group (yrs) SC1-2 SC3-4 SC5-6
9-11 3 5 1
12-14 16 20 20
15-17 35 33 40
Table 1.3: Percentages of children reporting that they are current smokers
Males
Age group (yrs) SC1-2 SC3-4 SC5-6
18-34 34 32 40
35-54 23 30 21
55+ 23 24 25
Females
Age group (yrs) SC1-2 SC3-4 SC5-6
18-34 27 34 22
35-54 11 16 8
55+ 8 15 21
Table 1.4: Percentage consuming more than recommended alcohol limits
by gender, age and social class
Although substantially fewer children reported that they had had an
alcoholic drink (32 per cent) than reported that they had smoked a
cigarette (49 per cent), abstinence rates declined rapidly across
adolescence for both boys and girls (Table 1.5). More than half of those in
the 15-17 year age group reported having an alcoholic drink in the
previous month, with higher levels seen in boys than in girls. A small but
consistent effect on social class was evident in girls but not in boys.
Food and nutrition
Thirty-two per cent of adult respondents reported a body mass index
(BMI) classifiable as overweight and 10 per cent were classifiable as obese.
More than half consumed less than the recommended 6+ servings per day
of cereals, breads and potatoes. Thirty-six per cent consumed less than the
recommended 4+ servings per day of fruit and vegetables. Twelve per cent
ate fried foods 4 times or more a week and there was a strong relationship
with social class and gender in this pattern (Table 1.6).
More than half of the children surveyed reported frequent (more than 3
times daily) consumption of high fat and/or high sugar foods (Table 1.7).
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Males
Age group (yrs) SC1-2 SC3-4 SC5-6
9-11 15 18 19
12-14 29 26 24
15-17 54 61 59
Females
Age group (yrs) SC1-2 SC3-4 SC5-6
9-11 7 2 4
12-14 13 16 19
15-17 49 50 52
Table 1.5: Percentages of children who have had an alcoholic drink in the
previous month by gender, age and social class
Males
Age group (yrs) SC1-2 SC3-4 SC5-6
18-34 22 25 32
35-54 11 12 15
55+ 16 18 21
Total 16 18 21
Females
Age group (yrs) SC1-2 SC3-4 SC5-6
18-34 6 6 16
35-54 5 5 9
55+ 6 7 8
Total 6 7 12
Table 1.6: Percentages consuming fried foods more than 4 times per week by
gender, age and social class
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Exercise
Overall, 42 per cent of adult respondents engaged in some form of regular
physical exercise. Rates declined markedly with age. Nearly one third of
those over 55 years took no exercise at all in a typical week.
It was found that the majority of children reported exercising outside of
school. However, boys exercised more than girls and there was a noticeable
drop in exercise participation in older children, again more marked in girls
(Table 1.8).
Accidents
Eighteen per cent of respondents reported an injury which had interfered
with their daily activity. The site of injury varied according to gender and
age. A higher percentage of females (74 per cent) always use the seatbelt
in the front seat of a car, compared to males (61 per cent). Of those
respondents who normally drank and who normally drove a car, 22 per
cent indicated that they had driven soon after consuming two or more
alcoholic drinks. A significantly higher percentage of males than females
reported doing this. Thirty-nine per cent of males in the 35-54 years age
group exhibited this behaviour.
Males
Age group (yrs) SC1-2 SC3-4 SC5-6
9-11 44 60 61
12-14 59 60 69
15-17 56 62 65
Females
Age group (yrs) SC1-2 SC3-4 SC5-6
9-11 41 54 60
12-14 46 56 62
15-17 44 52 52
Table 1.7: Children consuming high fat and high sugar foods frequently by
gender, age and social class
Males
Age group (yrs) SC1-2 SC3-4 SC5-6
9-11 66 74 64
12-14 69 68 65
15-17 54 55 54
Females
Age group (yrs) SC1-2 SC3-4 SC5-6
9-11 59 61 56
12-14 53 49 47
15-17 29 26 24
Table 1.8: Percentages of children participating in vigorous exercise four or
more times per week by gender, age and social class
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Less than half of the children overall reported that they always wear a
seatbelt when travelling by car, 35 per cent of boys and 46 per cent of girls.
Of the children who rode bicycles, only 8 per cent said that they always
wore a cycle helmet. The rate droppped progressively from 16 per cent at
ages 9-11, through 7 per cent at ages 12-14 to a very low 3 per cent at ages
15-17.
Summary
The information from the SLÁN and HBSC surveys provides an extremely
valuable overview of lifestyle risk factors at a national level and will
provide a benchmark by which progress in achieving targets can be
assessed in the future. There are several areas of concern in the findings of
the SLÁN survey. If the results are compared with those of several other
smaller surveys which have been conducted in recent years, the evidence
suggests that lifestyle risk factors have improved overall. However, it is
clear that strong socio-economic differentials are persisting. The reported
levels of smoking, alcohol intake, fat consumption and sedentary lifestyles
in many young people are disquieting and suggest that much more effort
is required to ensure that health improvements achieved over recent
decades are not undermined.
Population health surveillance 
Information on the health status of the population and on potential risks
to health is essential if we are to describe and monitor changes in
population health, identify health needs and use and manage health
services appropriately. This information should be available in a
systematic, structured way. A population health surveillance system would
fulfil that need.
Population health surveillance is defined as follows:
The ongoing systematic collection, assembly, analysis, and interpretation of
population health data, and the communication of the information derived
from these data, to stimulate response to emerging health problems, and for
use in the planning, implementation, and evaluation of health services and
programmes.
Information derived from a population health surveillance system has a
wide variety of uses. It allows real-time surveillance of disease and actions
to be taken if unusual events, e.g. outbreaks of disease, occur. It supports
and guides the management of health-care services. It aids the setting of
priorities for the development of health services. It allows for the
evaluation of services and the establishment of systems for quality
assurance and audit at all levels within the services. PHS is the knowledge
that should drive the whole course of health services for a community. In
the Irish context it should be the methodology by which the three key
principles of Shaping a healthier future (accountability, equity and quality)
are measured and evaluated.
There are many components to a comprehensive population health
surveillance system. They include the following:
• Demographic data
• Health status measurement
– Positive health measures 
– Ill-health measures
– Mortality data 
– Equity of health status
• Health risk measurement
– Biological
– Environmental
– Behavioural
• Health systems
– Health services utilisation, efficiency and effectiveness measures
– Health care resources.
Ireland already has some of the elements of a population health
surveillance system such as the Public Health Information System (PHIS),
the National Cancer Registry, and the recent Survey of Lifestyle, Attitudes
and Nutrition (SLÁN). Other elements exist in forms that need further
development. A huge amount of information which is of relevance to
health is collected by many different agencies inside and outside the health
services, e.g. census information, environmental data, economic data, and
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health service activity data in the hospital sector, general practice and
community care. The difficulty is that many data systems are not
compatible with each other and the data collected is not in a format which
permits analysis of health status and outcomes measures. Then there are
gaps where new systems need to be prioritised, e.g. the development of
quality measures in health-care, the measurement of disability in the
population and the identification of future health care needs. A co-
ordinated approach involving national and local agencies is essential if our
existing and future information resources are to be fully utilised.
It is important to note that population health surveillance, like all
information, is not cost free. A well-organised system of data collection
and analysis is required. This would entail, in the Irish context, both
regional and national components operating within an agreed structure. It
would require an individual information system for the separate
components and an overarching management information system for the
spectrum of information referred to above.
It is essential that this type of information becomes central to health
service planning. To achieve this, it has to be accessible to managers at
local level. Population health surveillance information should be available
in a variety of media from paper to website, in order to facilitate as wide a
dissemination and use as possible. The information should be analysed
and presented in formats useable by non-statisticians.
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It is widely accepted that
there are natural differences in
health in any population. Human beings
vary in health as they do in every other aspect of
life. In 1980 a research working group on
Inequalities in Health in the UK published a report which
had some disturbing findings. This report, which has
become known as the Black Report, found that there were
large differentials in mortality and morbidity between the
higher and lower social classes in Britain.
The research group came to the conclusion that health
inequalities were primarily a consequence of material
differences in living standards. They argued that much of
the problem lay outside the scope of the health services.
Social and economic factors like income,
unemployment, environment, education,
housing, transport, and ‘lifestyle factors’ all
affect health, and all favour the
better off.
Inequalities
in Health 2
The recommendations of this report pointed to a wide range of social
policy measures to combat inequalities in health. In Ireland, Nolan’s
report, ‘Socio-economic Mortality Differentials in Ireland’, documented
similar findings to those in the Black Report. Based on 1981 mortality and
census data, this report showed significant differences in standardised
mortality rates between professional/managerial occupational groups and
semi-skilled or unskilled workers.
Over the past 10 years, there has been considerable international research
into measuring and monitoring social inequalities in health. It has been
demonstrated in many developed economies including the Netherlands,
Finland, Sweden, Spain, West Germany, Switzerland, Australia and the
USA that those whose socio-economic status is less than that of the wider
community in which they live suffer a significantly disproportionate
burden of ill-health and premature death.
Target 2 of the World Health Organisation’s European Region’s Health 21
Strategy (to which Ireland is a signatory) states that by the year 2020, the
health gap between socio-economic groups within countries should be
reduced by at least one quarter in all member states, by substantially
improving the level of health of disadvantaged groups.
Shaping a healthier future (1994) made a commitment to the principle of
equity of access to health care, recognising the importance of paying
special attention to geographical areas or population groups where the
indicators of health status are below average.
Causes of inequalities in health
The factors producing the observed relationship between socio-economic
status and physical ill-health are complex. Social inequalities in health are
believed to result from a variety of cultural and behavioural factors
including the following:
• Health-related behaviour and biological risk factors
• Material conditions: unemployment, lack of access to adequate
housing, poor transport, etc
• Low educational attainment
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• Factors operating early in life: genetic, biological, results of early life
experiences
• Psycho-social factors: lack of control over working lives, poor support
networks, stressful life events including violence and abuse
• Inadequate medical care.
The existence of inequalities in health are not likely to be explained by any
one of the above factors. It is likely that such inequalities result from an
interplay of genetic, biological, social, environmental, cultural and
behavioural factors.
The Irish situation
Up until the early 1990s, little work had been done on socio-economic
differences in health in Ireland. However, since then, a series of reports
have examined aspects of this problem and identified a number of
concerns:
• Based on data from the 1980s and 1990s, for men aged 50 to 64 years,
significant differentials in standard mortality rates exist between
professional/managerial occupational groups and semi-skilled or
unskilled manual categories.
• Perinatal and infant mortality rates are higher in families where the
father is an unskilled manual worker or is unemployed.
• There is a higher incidence of reported chronic illness for unskilled
manual classes as compared to the professional and managerial classes.
• Sections of the Irish population who are marginalised, e.g. Travellers,
have a particularly heavy burden of illness and premature death.
• It is possible to identify specific geographical areas where increased
mortality rates and the incidence of low birth-weight babies are
significantly higher than other areas. These areas (black spots) can be
identified by reference to indicators of serious socio-economic
deprivation.
• Two national surveys of health-related behaviours among adults
(SLÁN) and school-going children (HBSC) in 1998 found that those
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in lower socio-economic groups had significantly less healthy
lifestyles than those in higher socio-economic groups. This suggests
that socio-economic differences in health in this country are likely to
continue.
• There is evidence that the less well-off in society have poorer access
to health services. Recent documentation suggests that there are
substantial variations in the provision of diagnostic, therapeutic and
rehabilitation services for coronary heart disease. Such inequities in
service provision must be addressed.
Already a number of initiatives have been introduced in this country aimed
at reducing inequalities in health, for example the Community Mothers’
Programme. It is encouraging to see the development of initiatives such as
this to help reduce inequalities in health within communities and these
should be supported. However, it is important that these projects become
part of a large broad-based national strategy, so that their overall
effectiveness and impact can be evaluated.
Conclusions
• There is strong and consistent evidence for a relationship between health
and socio-economic status. Deprivation is associated with poor health.
• Inequalities in health status between socio-economic groups have
been demonstrated in this country and are persisting. 
• Health is determined by a wide range of factors of which availability
and quality of health services is only one.
• To improve the nation’s health, a holistic rather than a service-
oriented approach is needed across all sectors of government.
• Government must take responsibility for the wider influences of its
policies on health in order to facilitate the development of a social and
economic environment in which health inequalities can be reduced.
Issues for consideration
It is important that the needs of people who are suffering the effects of
health inequalities are placed at the centre of plans for health and social
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improvement, as has been done in the current National Anti-Poverty
Strategy document. However, any strategy relating to health inequalities
must be broad-based and must be committed to tackling the underlying
problems of social and economic inequality.
Inter-sectoral collaboration
Many of the causal factors of health inequalities, such as poverty and
unemployment, are outside the direct control of the health services. Inter-
sectoral collaboration is required to tackle these problems, and partnership
between government and the statutory and voluntary sectors is vital if the
cycle of inequality is to be broken. Close co-operation between the
Departments of Health and Children, Education and Science, Environment
and Local Government, Community and Family Affairs, Agriculture and
Food, and Finance will be required to address this important issue. 
The Institute of Public Health
The Institute of Public Health was set up in 1998 under an agreement
between the Department of Health and Social Services in Northern Ireland
and the Department of Health and Children in the Republic of Ireland. The
Institute is committed to working in partnership with other agencies in
addressing health inequalities on an all-Ireland basis. It is anticipated that
it will play an important role in the areas of information, research, inter-
sectoral working and policy advice on this issue.
Information needs
Changes are required to existing information systems which could greatly
improve our ability to identify and monitor health inequalities. Routine
small area coding of births, deaths and hospital discharges for the whole
country, and collection of accurate social class data for vital events and
hospitalisation would greatly enhance our ability to contribute to the
surveillance of the health of the population.
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Research
Research is urgently required to establish the extent of health inequalities
in Ireland and the complex causes of these inequalities, including
inequalities in access to health care such has been highlighted in the recent
Cardiovascular Strategy document, Building healthier hearts (1999). This
also includes undertaking research to help decide what works best.
Health equity impact assessment
All policies likely to have a direct or indirect effect on health should be
evaluated in terms of their impact on health inequalities, and should be
formulated in such a way that by favouring the less well-off they will,
wherever possible, reduce such inequalities.
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Cardiovascular disease (which includes heart
disease, strokes and circulatory disorders) is the
single highest cause of mortality in this country and a
major cause of premature mortality. Over 1,800 people died
prematurely from cardiovascular disease in 1997. In
addition to those who die prematurely, many others suffer
chronic ill-health and reduced quality of life.
Cardiovascular disease was identified as a priority in the
Health Strategy Shaping a healthier future (1994). The
Health Strategy set a medium-term target to reduce the
death rate from cardiovascular disease in the under-
65 year age group by 30 per cent over a ten year
period and it would seem that we are in line to
achieve this. However, this is no cause
for complacency. 
Cardiovascular
Disease 3
Although there have been significant reductions in mortality from
cardiovascular mortality in recent decades, Ireland’s position in the
league table of European countries is very poor. Also, there is evidence
that the burden of cardiovascular disease on the health services may
actually be increasing despite the fall in mortality, due to an increase in
the number of chronically ill, older patients.
Within Ireland, the burden of coronary heart disease (CHD) is not
distributed equally in society. On the basis of both international and
national evidence, we know that cardiovascular diseases are more
common among the socio-economically disadvantaged. The recent
national SLÁN survey found that those in lower socio-economic groups
are more likely to smoke, less likely to be physically active and less likely
to eat a healthy diet than those in higher socio-economic groups. Socio-
economic differentials in cardiovascular health are likely to continue
unless strong multi-sectoral health promotion and preventive activities
are specifically targeted at addressing these inequalities. There are also
important regional inequities. Cardiovascular mortality rates are
significantly higher in some areas of the country. Hospital utilisation
figures suggest that there is regional inequity in access to services.
Ireland’s high rates of cardiovascular disease are not inevitable. There is
a great deal that can be done to address the problem. The Cardiovascular
Health Strategy Group (CHSG) was established by the Minister for
Health and Children in March 1998 to develop a strategic approach to
further reduce death and illness caused by cardiovascular disease. The
CHSG focused on the prevention and management of coronary heart
disease, which is the major cause of death and disability within this
group of diseases. The report of the CHSG, Building healthier hearts, was
presented to the Minister in July 1999. 
The challenge now is to implement the recommendations of the CHSG
by developing structures and mechanisms which promote cardiovascular
health, reduce social inequalities, ensure a high quality of service
provision and reduce variations in access to and quality of services.
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Epidemiology
Mortality
Cardiovascular diseases are a major health burden and cause over 40 per
cent of all mortality in Ireland. Within this group of diseases, ischaemic
heart disease or coronary heart disease (CHD) accounts for most of this
mortality and is the cause of almost one quarter of deaths at all ages.
Cerebrovascular diseases or stroke are also a major cause of death and
account for approximately 10 per cent of all deaths (Figure 3.1).
The epidemiology of cardiovascular disease is undergoing significant
change. Cardiovascular disease has been declining as a cause of death in
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Fig 3.1: Deaths by Principal Causes, Percentage Distribution, 1998
Source: CSO
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Fig 3.2: Coronary Heart Disease: Trends in age-standardised death rates,
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Ireland and throughout the western world in recent decades. Irish CHD
death rates have fallen by about 30 per cent in the past 20 years but remain
very high when compared with other EU countries (Figure 3.2). Ireland
has the highest rates for premature mortality from CHD in the EU for both
males and females (Figure 3.3).
CHD affects men at a younger age than women. Age-specific mortality
rates start to rise at a younger age in men than in women, and men have
higher death rates from CHD at all ages (Figure 3.4).
There is some geographic variation in the mortality from CHD nationally.
Age-standardised death rates from this cause are highest in the North
Eastern and Southern Health Board areas and lowest in the North Western
Health Board area (Figure 3.5).
Cerebrovascular mortality rates have fallen considerably in recent decades
and Irish mortality figures from this cause now compare favourably with
the EU average (Figure 3.6). However, stroke continues to be a major
3 6 C a r d i o v a s c u l a r  D i s e a s e 
50
60
70
80
90
100
0
20
30
40
10
M
or
ta
lity
 ra
te
 p
er
 1
00
,0
00
Austria Belgium Denmark Finland France Germany Greece Ireland Italy Portugal Spain Sweden UKNetherlandsLuxembourg
Fig 3.3a: Coronary Heart Disease: Age-standardised death rates in
EU Countries (Males, 0-64 Years, last available year)
S
ou
rc
e:
 H
ea
lt
h
 f
or
 A
ll
 D
at
ab
as
e,
 W
H
O
15
20
25
0
5
10
M
or
ta
lity
 ra
te
 p
er
 1
00
,0
00
Austria Belgium Denmark Finland France Germany Greece Ireland Italy Portugal Spain Sweden UKNetherlandsLuxembourg
Fig 3.3b: Coronary Heart Disease: Age-standardised death rates in
EU Countries (Females, 0-64 Years, last available year)
S
ou
rc
e:
 H
ea
lt
h
 f
or
 A
ll
 D
at
ab
as
e,
 W
H
O
cause of hospital admission. This disease has a major impact on an
individual’s quality of life and poses a heavy social and economic burden
on the patient, the family and the community.
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Morbidity
Information on deaths from cardiovascular disease gives a very incomplete
picture of the pattern of these diseases and the burden they place on the
community. Despite the fact that mortality from cardiovascular diseases
has declined, the overall incidence is likely to increase as the population
ages and survival after acute cardiac events such as heart attack improves.
This has implications for the health services as, paradoxically, the burden
of cardiovascular disease in the population may be increasing as mortality
is falling.
Unfortunately the cardiovascular morbidity data available to us is limited.
We do not have information systems to make an accurate judgement of
changes in disease incidence or prevalence in the community. There are no
routinely available primary care level data sources. Hospital utilisation
3 8 C a r d i o v a s c u l a r  D i s e a s e 
200
0
100
M
or
ta
lity
 R
at
e 
pe
r 1
00
,0
00
1970 1975 1980 199519901985
Ireland
EU Average
Fig 3.6a: Cerebrovascular Disease: Trends in age-standardised
death rates, Males, 1970-1995: Ireland and EU
S
ou
rc
e:
 H
ea
lt
h
 f
or
 A
ll
 D
at
ab
as
e,
 W
H
O
S
ou
rc
e:
 H
ea
lt
h
 f
or
 A
ll
 D
at
ab
as
e,
 W
H
O
200
0
100
M
or
ta
lity
 R
at
e 
pe
r 1
00
,0
00
1970 1975 1980 199519901985
Ireland
EU Average
Fig 3.6b: Cerebrovascular Disease: Trends in age-standardised
death rates, Females, 1970-1995: Ireland and EU
data pertaining to discharge diagnosis and uptake of cardiac procedures
may reflect regional referral and availability patterns rather than true
differences in disease prevalence.
Figures from the recent SLÁN survey suggest that about 10 per cent of men
in the 55-64 year age group have some form of heart disease, while in the
over-65 year age group, at least one in five people of both sexes are affected.
Prevention
A large proportion of cardiovascular mortality and morbidity is
preventable. The risk factors associated with CHD and other
cardiovascular diseases are well known. Modifiable risk factors include
smoking, high blood pressure, high cholesterol levels, physical inactivity
and obesity. It is difficult to quantify the potential extent of lifestyle change
on mortality but we know that modification of classic risk factors reduces
disease incidence.
Although Irish death rates have declined, it is clear that more can be done.
Other countries, such as the US, Australia and Finland, which had higher
death rates than Ireland in the 1960s, now have lower levels. It has been
estimated that 25 per cent of the reduction in mortality observed in the US
can be attributed to primary prevention, 50 per cent to cardiological and
surgical interventions to treat acute events, and 25 per cent to secondary
prevention in those with the disease.
The most up-to-date information available about cardiovascular risk
factors at population level is that collected in the recent SLÁN survey. The
findings of this survey give cause for concern. Smoking rates are rising,
particularly in young women and teenagers. Continuation of this trend
could see a reversal of the reduction which has been observed in mortality
rates in the past few decades.
The risk factors associated with heart disease are also associated with a
wide range of other conditions including strokes and other circulatory
disorders, diabetes, and cancers. Strategies aimed at reducing CHD should
also bring about substantial reductions in these conditions.
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Treatment
There have been major advances in CHD treatment in recent years which
have contributed to the observed reduction in mortality. These treatments,
which include thrombolysis and other drug therapies, coronary
angioplasty and cardiac surgery, are of proven efficacy and can reduce
complications, increase survival and reduce risk of a further event.
The cardiovascular disease strategy
The changing epidemiology of cardiovascular disease, its largely
preventable nature, and the significant developments in management and
treatment options available, all have significant implications. An ageing
population, and improved survival after acute cardiovascular events, has
increased the burden of care on the health system. It is essential to optimise
services for patients presenting with cardiovascular problems in order to
ensure a high quality, equitable service and to enhance the continuing
downward trend in death rates. Also, it is clear that further reductions in
mortality are achievable. A strategic commitment to primary prevention is
required to ensure the cardiovascular health of the next generation and to
address the serious health inequalities in our community.
The Cardiovascular Health Strategy Group (CHSG), established by the
Minister for Health and Children in March 1998, focused on the prevention
and management of coronary heart disease, which is the major cause of
death and disability within this group of diseases. The report of the group,
Building healthier hearts (1999), included 211 recommendations.
Four key areas for action were identified:
• Standardise acute care in the pre-hospital and hospital setting across
health board regions.
• Establish a protocol for appropriate primary care.
• Ensure an effective surveillance system.
• Expand or put in place settings-based health promotion activities.
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Need for multi-sectoral involvement
Implementation of the recommendations in Building healthier hearts will
pose a major challenge, not only to the health services, but to the wider
community both public and private. It is clear that committed multi-
sectoral action is required if primary prevention at a population level is to
be effected. Major population lifestyle changes in smoking, alcohol
consumption, diet and physical activity cannot be achieved by the health
services on their own. Special attention will be required to promote health
in disadvantaged groups with low income or low levels of education. This
strategy should produce not only substantial cardiovascular health gains,
but also significant benefits in other areas of morbidity and mortality such
as strokes, cancers, diabetes and general mental well-being. The
establishment of the National Heart Health Task Force is an important first
step in driving this process forward.
Health service challenges
The importance of multi-sectoral collaboration to achieve reductions in
CHD incidence through primary prevention cannot be over-emphasised.
Additionally, the CHSG identified several significant deficiencies in
current health service provision to patients presenting with either
established cardiovascular disease or with risk factors for the disease.
Addressing these deficiencies will require a co-ordinated approach across
all levels of the health services and the involvement of management,
clinicians and professional bodies. An expert Advisory Forum has been
established to advise the Department of Health and the National Heart
Health Task Force on the practical issues arising from the implementation
of the strategy. Regional implementation structures are being established in
each health board.
The following are some of the major issues which will have to be addressed
by the new implementation bodies.
Regional inequities
The CHSG discovered substantial regional variations in the provision of
diagnostic, therapeutic and rehabilitation services for CHD. These
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variations cannot be explained solely by regional variations in disease
prevalence, but must reflect variations in professional referral patterns
and/or regional inequities in access to these procedures. Such variations
are clearly unacceptable.
Evidence-based practice
Ensuring that internationally accepted best practice as determined by
research evidence becomes part of routine clinical practice is a challenge
facing all health administrations. There have been major advances in CHD
diagnosis and treatment in recent decades including thrombolysis and
other drug therapies, coronary angioplasty and cardiac surgery. A
substantial body of research evidence underpins these developments,
establishing what works best, in whom, and when it should be given.
However, the CHSG found in a number of instances some evidence of
inconsistent implementation of internationally recognised best practice
and evidence-based treatment. More commonly, it was impossible to
determine from available information if such practices were being
followed.
Action is required on a number of fronts to tackle these difficulties.
Commissioning the development of protocols and guidelines of best
practice at national level will be a major function of the new Advisory
Forum. This process will require input from professional bodies and
academic departments of medicine. Experience elsewhere has shown that
dissemination and adoption of guidelines at local level requires ongoing
commitment of resources. Specific structures and dedicated personnel will
have to be put in place regionally to facilitate this.
Performance measurement and development of health
information systems
The lack of health information data relating to morbidity patterns and
service provision was a major difficulty experienced by the CHSG in
compiling its report. Improvement in health information availability is
essential for future planning of services and for monitoring the equity and
quality of service provision. The introduction of performance
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measurement systems to monitor implementation of the group’s
recommendations and to identify resultant health and social gains cannot
proceed without significant health information developments.
There is an almost complete lack of organised health information
collection at the primary care level, and many GP practices are not yet
computerised. Unless this deficit is addressed, it will be impossible to
evaluate the benefits attached to any primary or secondary preventive
measures which may be introduced at general practice level in the future.
Reorientation of services to prevention and health promotion
One of the principal recommendations of the CHSG report was that there
should be an increased focus on the provision of appropriate preventive
services in both primary care and secondary care. The report pinpointed
general practice as a key setting for the identification of individuals at high
risk of developing CHD, and for the delivery of appropriate supportive
services to enable patients to make the necessary changes in their
lifestyles. Apart from the obvious monetary and manpower resource
implications of the re-orientation of general practice to cover preventive
services, there are other important areas to be considered.
Preventive services, like any other service, have to be founded on evidence
of benefit. There are many reports in the international literature of
prevention initiatives which have produced little or no benefit.
Developments in this field will have to be carefully planned and
subsequently monitored to ensure that resources are deployed to
maximum effect.
Widespread population screening for cardiovascular risk factors would not
be cost-effective. The evidence is clear that the greatest benefit will derive
if preventive measures are focused in the first instance on those with
established CHD and those at highest risk. At the moment, there is no
system whereby these target groups can be readily identified. All practices
involved in providing this type of service should be computerised. This
would allow the development of practice lists of at-risk groups and
facilitate the evaluation of the service.
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Cerebrovascular diseases
This chapter has dealt principally with coronary heart disease, because
that is the main cause of death and morbidity within this group of diseases,
and it was the subject of the CHSG report Building healthier hearts (1999).
The two other major types of cardiovascular diseases are cerebrovascular
disease or strokes and peripheral vascular disease, a major cause of
morbidity. Cerebrovascular mortality rates have fallen considerably in
recent decades. However, stroke continues to be a major cause of hospital
admission. This disease has a significant impact on an individual’s quality
of life and poses a heavy social and economic burden on the patient, the
family and the community.
The risk factors associated with these diseases are largely the same as those
for CHD, and at a population level the health promotion and preventive
measures proposed by Building healthier hearts should also result in
significant reductions in the incidence and severity of these diseases.
However, the specifics of diagnosis and management of these diseases are
quite different from those of CHD. With an ageing population and
increased survival of younger adults as a result of falling incidence and
better management of CHD, a heavy ongoing burden of cerebrovascular
disease can be expected. The management of cerebrovascular disease has
seen significant developments in recent times, with increasing
indications for the use of pharmacologic and other interventions. The
provision of rehabilitation services to stroke patients is crucial in
enabling them to achieve optimal recovery. The provision of stroke
services is an important area of health service delivery which should be
reviewed as a matter of priority.
Conclusion
There are several significant benefits which can be expected to accrue from
the implementation of the strategy outlined in Building healthier hearts.
Apart from the health and social gains in cardiovascular diseases and other
areas as outlined above, implementation should result in improved co-
ordination and efficiency of health service provision. Implementation of
the strategy should serve as a model for improvements, particularly in
respect of such areas as the standardisation and co-ordination of services,
the development of national guidelines and protocols, and the
introduction of systems for surveillance and performance measurement.
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Cancer is a common global
problem that is costly to the health
services, the individual, the family and society.
It is the second most frequent cause of death and
was identified in Shaping a healthier future as an area
that needed to be urgently tackled. Cancer tends to create
a sense of fear and helplessness partly because of its
insidious onset and lack of symptoms in the early stages,
the side effects associated with some treatments, and the
perception that it involves long-term pain and suffering.
A diagnosis of cancer may lead to psychological problems
for many patients and their families and creates a degree
of panic that is not experienced to the same extent in
other diseases. It is estimated that one third of
cancers are preventable, and one third are
potentially curable. Good palliative care can
provide significant improvements in
quality of life.
Cancer
4
Careful planning is essential if the resources available to us are to be
utilised to achieve the maximum benefit for our whole population.
Epidemiology
The risk of contracting and surviving cancer varies throughout the world
and among different socio-economic and demographic groups. Various
developments in urbanisation and technology have affected the occurrence
of cancer through their impact on lifestyles and environmental exposure.
The establishment of national cancer registries to collect cancer data in a
number of countries has improved our knowledge about cancer and our
ability to examine the variation in occurrence among different populations.
There is a wealth of information available in the National Cancer Registry
Ireland for those who wish to examine the profile of cancers occurring in
Ireland. Many of the most common cancers can be prevented by lifestyle
changes. Smoking is the single biggest preventable cause of cancer.
Incidence and mortality
Cancer is becoming increasingly significant as a cause of mortality in our
population. The overall death rate from cancer in Ireland has increased
since the 1970s (Figure 4.1), and because of a reduction in other causes of
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death, the proportion of deaths due to cancer has increased. In 1996,
20,818 new cases of cancer were recorded in Ireland and 7,436 people died
from cancer. Approximately one in four deaths are due to cancer. Apart
from non-melanoma skin cancer (35 per cent), the most commonly
occurring cancers in the general population are cancers of the lower bowel
(9 per cent), breast (8 per cent) and lung (7 per cent). Commonly
occurring cancers in women are: cancers of the breast (16 per cent), cervix
(9 per cent), and lower bowel (7 per cent), and in men: cancers of the
prostate (11 per cent), lower bowel (10 per cent) and lung (9 per cent). The
most common cause of cancer death in men is lung cancer (23.9 per cent)
and in women it is breast cancer (18.5 per cent).
Cancer in Europe 
Cancer is the second leading cause of death in Europe. When account is
taken of differences in age structure between EU member states, the risk of
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Fig 4.2a: Cancer: Age-Standardised Death Rates in EU Countries,
Males, last available year
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Fig 4.2b: Cancer: Age-Standardised Death Rates in EU Countries,
Females, last available year
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dying from cancer among men is highest in Belgium and lowest in Sweden
(Figure 4.2a). Ireland ranks sixth. The risk of dying from cancer among
women is highest in Denmark and lowest in Greece (Figure 4.2b). Ireland
ranks second. The lower mortality rate for cancer in the Mediterranean
countries is partly due to lower rates of breast and bowel cancer.
Individual cancers
Cancer of the colon and rectum
Ireland has a high rate of colorectal cancer where it is the second most
common cancer after skin cancer. There were 1,792 new cases and 896 deaths
in 1996. Cancer of the colon is a disease of economically developed countries
and it affects both sexes almost equally. Rectal cancer is usually more
common among men. Environmental factors play a major role in the
aetiology of the disease, the most important being diet. Most distal colorectal
carcinomas arise in benign adenomas, with a slow transition time to
malignancy of 10 to 15 years. Many patients seek treatment at a late stage and
the prognosis is poor when the tumour has spread beyond the bowel wall.
Theoretically, screening procedures that detect and lead to the removal of
adenomas or early cancers should result in a decrease in mortality. Faecal
occult blood testing in men and women age 50 to 69 years has been found
to reduce colorectal cancer mortality. This test is being considered as a
preventive measure in a number of European countries. The feasibility of
flexible sigmoidoscopy and colonoscopy in screening is also being
evaluated. Studies of screening by dedicated researchers among motivated
populations have shown reduction in the mortality from colorectal cancer.
This does not mean that the introduction of mass screening would lead to
similar benefits. Until screening has been shown to be a feasible and
effective method of reducing mortality from colorectal cancer in the Irish
context and the benefits and risks have been carefully evaluated, screening
cannot be recommended on a population basis in Ireland.
Lung cancer
Lung cancer is the most common cause of cancer deaths in Ireland. There
were 1,456 new cases and 1,464 deaths in 1996. The rate is higher in men
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Fig 4.4b: Lung Cancer: Age-standardised death rates in EU Countries,
Females, last available year
than women (Figure 4.3). The low survival rate occurs partly because of the
advanced stage at diagnosis. Geographical variations in lung cancer have
been noted and are attributable to different smoking patterns in different
populations (Figure 4.4a and Figure 4.4b). Irish women have the third
highest rate of lung cancer in the EU (Figure 4.4b). The level of lung cancer
has increased due to an increase in smoking. The increase in lung cancer
among women is a particular cause for concern and reflects the differential
rates of smoking between the sexes. Among younger women the smoking
rates are now 40 per cent while the level of smoking for the population
overall is 31 per cent. This is an area that requires urgent action.
Prostate cancer
In Ireland, prostate cancer is the most common form of cancer occurring
in men excluding non-melanoma skin cancer and the second most
common cause of cancer death among men after lung cancer. It accounts
for 13 per cent of all cancer deaths among men. There were 1,138 new cases
and 523 deaths in 1996. It is a disease that mainly affects older men and this
will become a more significant problem as the male population is ageing.
Both genetic and environmental factors play a part in the development of
prostate cancer. An apparent increase in the incidence of prostate cancer
has been noted internationally. It may be partly explained by an ageing
population, by an increase in the number of asymptomatic subjects
requesting screening, the availability of screening in some countries,
improved diagnostic accuracy and improved registration of the disease.
Curative treatments for prostate cancer are limited to early stages of the
disease. An effective method of early detection of prostate cancer that
would lead to a reduction in mortality would be useful. However, experts
in the area are divided regarding the existence of a reliable screening tool
that could be used in mass screening to reduce mortality from prostate
cancer. Screening for prostate cancer has the potential to reduce mortality
only if it can distinguish clinically significant cancers from those of little
clinical significance. Currently-available tests cannot distinguish between
tumours that are life threatening and tumours that might remain clinically
dormant. There is no clear evidence yet available to indicate that clinical
outcome is improved by early detection. Unnecessary interventions should
be avoided. Randomised controlled trials are being undertaken in a
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number of countries to evaluate the benefit of screening for prostate cancer
using a number of tests. Until the evidence of benefit is available it would not
be appropriate to introduce mass screening for prostate cancer in Ireland.
Breast cancer
Breast cancer is the most frequent cause of cancer death among women. In
Ireland there were 1,601 new cases and 641 deaths in 1996. Breast cancer
is responsible for almost one in five cancer deaths in women. It occurs
infrequently before the age of 40 but then becomes increasingly more
common with age. International comparisons of death from breast cancer
reveal wide variation in the death rates. Ireland ranks high alongside other
northern European countries such as Denmark, UK and the Netherlands
(Figure 4.5). The great variation in breast cancer among different countries
and the change in risk of breast cancer in migrants from low incidence to
high incidence areas and in their descendants has been interpreted as a
strong indication that environment and lifestyle influence the risk of breast
cancer. There is a positive association between late childbearing and
nulliparity and breast cancer. In younger women genetic predisposition
may be a more significant factor than reproductive status.
The most important prognostic indicator is stage at diagnosis. In many
countries early diagnosis through screening has enabled many women to be
treated successfully. In these countries an increase in incidence is not
matched by an increase in mortality. In Ireland, the National Breast
Screening Programme has been launched and the first women are due to be
screened shortly. It will be a state of the art programme that will target
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women in the 50-64 year age group. Women outside this age group will
attend the existing symptomatic clinics. This service will be augmented to
ensure that women who have symptoms receive an equally excellent service
to those who are discovered through screening to have breast cancer.
Cervical cancer
Cancer of the cervix is the second most common cause of cancer among
women worldwide but 80 per cent of these cancers occur in developing
countries. In Ireland, there were 999 new cases and 82 deaths in 1996. A
decline in the incidence and mortality rates for cervical cancer has been
observed globally. Where effective national screening programmes have
been introduced, mortality has fallen substantially. In Ireland, preparations
for Phase One of the National Cervical Screening Programme are nearing
completion. The intended start-up date is March 2000. Work is also
underway to ensure that the infrastructure for the programme is in place
nationally. This will facilitate the smooth transition from Phase One to the
full national programme without undue delay.
Cancer prevention
Cancers occur as a result of the interplay between genetic and
environmental factors. Risk of cancer depends on age, sex, genetic make-
up, where we live and how we live. To some extent certain aspects of cancer
risk are within our own control. We now have sufficient information to
contribute to the prevention of a majority of the most common cancers –
those associated with lifestyle. The effect of diet modification to reduce
cancer risk is an area of increasing significance and it is amenable to
individual control. Diet is the subject of much research but it is thought
that action in this area could result in a 30 per cent reduction in cancer. The
most sensible action is to eat a balanced diet with an increased intake of
fresh fruits and vegetables, high fibre whole grain breads and cereals, and a
decreased consumption of animal fat and red meat.
It is estimated that 30 per cent of all cancers owe their origin to smoking.
Smoking is implicated in a number of cancers including lung, bladder,
kidney, stomach, liver, nasal sinuses, larynx, pharynx, oesophagus,
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pancreas and cervix. Prevention of smoking would lead to a substantial
reduction in death and morbidity associated with cancers and other
illnesses such as cardiovascular disease and chronic lung disease. Tackling
the problem of tobacco control is not easy. There are many factors that
influence the decision of individuals to smoke. Choices are affected by
social influences and by the powerful vested interests of tobacco
companies. Advertising and the sponsorship of sporting activities reinforce
the social acceptability of the product and undermine the effectiveness of
health promotion activities that aim to reduce the prevalence of smoking.
Smoking is also an economic issue because the tobacco industry provides
employment and income to many sectors and is a source of tax revenue to
the government. However, if all costs to society were calculated (health
care costs, working days lost, pain and suffering to individuals and their
families, etc.) it would be clear that there is a net loss to society.
There is a need for alternative economic strategies to be devised which
would reduce the production and consumption of tobacco, with minimum
immediate harm to the economy. This requires action across a number of
government departments and at EU level. A comprehensive tobacco policy
is required to reduce the health consequences of tobacco. This should
include preventing young people from starting to smoke, helping smokers
to quit, increased taxes on tobacco, total bans on advertising (direct and
indirect), provision of smoke-free enclosed public areas, effective health
warnings on tobacco products, and health education. Smoking is a public
health problem that requires urgent attention.
Interventions to ensure earlier detection of cancer range from educational
initiatives to formal population-based screening strategies. In screening,
the health services seek out apparently healthy individuals and ask them
to undergo a procedure that will lead to a benefit. When deciding on the
implementation of a screening programme it is essential that one can
ensure that the collective benefit will outweigh any harm from the
programme. It is sometimes believed that the ability of a test to detect a
disease is in itself sufficient reason to screen, even if there is no evidence
of improved outcome. Some believe that the epidemiological importance
of a disease is sufficient justification for screening, pending definitive
evidence of effectiveness. It is important to ensure that the policy on what
is and is not screened is carefully thought out and that programmes which
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are put in place are of the highest quality. Population screening
programmes should only be undertaken when their value has been proven
and resources and facilities exist to conduct a quality programme. 
Cancer services
The main purpose of cancer treatment services is cure, prolongation of life
and improvement of quality of life. Over the years, although a magic cure
has not been discovered, there has been a steady improvement in the quality
of care. Surgery has become more conservative due to technological
improvements, radiotherapy has become more precise, and the role of
chemotherapy has become more defined and its administration less
unpleasant. There has been a significant improvement in our understanding
of cancer at a molecular level. Continuing research will lead to less toxic and
more effective treatments. All patients throughout the country should have
access to a high quality of care that includes good diagnostic practice,
effective primary care, and well-developed treatment services. Depending on
the type of cancer, the treatment may involve surgery, radiation therapy,
chemotherapy, hormonal therapy or a combination of these. Some
treatments require sophisticated technology only available in specialised
locations. Others are available at regional or local level. Primary care is an
important element in cancer care, co-ordinating management of medical
treatment and psycho-social aspects throughout the illness. Patients with
cancer place a high value on quality of life. Palliative care is an integral part
of any cancer service and should be easily accessible to everyone locally, both
in the hospitals and in their homes.
To a certain extent in the past cancer services developed in an ad hoc
fashion. Ideally, the services should be based on agreed current best
practice, using the treatments and organisational arrangements that are
likely to achieve the best results. Resources must be mobilised to maximise
the benefit that can be gained from them. Agreed referral and clinical care
guidelines that can be audited are an important part of any comprehensive
cancer care service. The cancer service must be based on an integrated
multi-institutional approach determined by the needs of patients rather
than by accidents of residence, location of services, or traditional patterns
of referral. In an effort to deal with some of the weaknesses in the system
5 4 C a n c e r
and to build on the strengths, the National Cancer Strategy has established
an infrastructure to support development of the services. The National
Cancer Forum was formed in 1997 to advise on the implementation of the
National Cancer Strategy and Regional Directors of Cancer Services were
appointed to oversee the development of cancer services in each health
board area. Expert advisory groups have been set up to advise on specific
issues such as breast screening and cervical screening. The latest advisory
group to be established is the Palliative Care Advisory Committee. The
organisation of cancer services will now operate through supra regional
services in Cork, Dublin and Galway (responsible for treating the full
range of cancers within their catchment areas, with some exceptions, e.g.
for rarer cancers) and regional services (provided by designated groups of
hospitals treating specific cancers according to the agreed best practice).
The ‘National Cancer Institute All Ireland Partnership’ is an exciting
initiative that will lead to a further improvement in the quality and range
of cancer services available for patients in Ireland. It will provide
opportunities for joint programmes for cancer treatment, education and
research between the North and South of Ireland and the National Cancer
Institute in the USA. The main components will include consolidation of
cancer registries, education and exchange programmes for professionals,
enhancement of clinical trials, teleconferencing to facilitate education, and
improvement in cancer clinical services.
Conclusions
Cancer is becoming more significant as a health problem in our society. The
National Cancer Strategy has achieved much in terms of developing
infrastructure, tackling regional variations in service, etc. This work is
continuing and we will continue to see improvements in the provision of
services. It is now time to consider what people can expect from the services
in terms of outcomes and quality of care. The impetus has come from the
Royal Colleges and international literature with the development of clinical
guidelines, clinical indicators and recommendations for best practice. It is
important that this focus on quality is supported and nurtured.
Prevention is another important area that requires action. We have the
knowledge to help prevent many of the common cancers. We need to
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translate that knowledge into interventions. This may sometimes entail
making unpopular decisions. In addition to lifestyle modifications at the
community and individual level, any sound preventive effort has to tackle
socio-economic issues and ensure the development and implementation of
healthy public policies. We have achieved much but a lot of work remains
to be done.
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Injuries are a
major cause of death in
Ireland but there is wide scope for
reducing them. They are the leading cause
of death, ill-health and disability in children and
young adults. They are also a significant problem in
the elderly. They represent a larger burden on the health
system than many other health problems and the financial
and social costs of injuries are high. The cost in terms of
years of potential life lost under 65 is higher than for
cancer or cardiovascular disease.
Shaping a healthier future identified injuries as an
important area to target. However, this is a health problem
that does not receive as much attention from the medical
profession and from policy-makers as other health
issues. One possible reason for the neglect is the
widely-held view that injuries are caused by
accidents, which are random occur-
rences that cannot be prevented.
5
Injury
Part of the problem is the prevailing use of the term ‘accident’. This implies
that injuries sustained are totally beyond our control. In fact, such injuries
are preventable. Usually a combination of a sequence of events leads to an
episode that results in an injury. Opportunities for prevention occur at
each stage. When policy-makers hold the view that injuries are inevitable,
a major barrier to progress in injury prevention is created.
Another difficulty in tackling injuries is the fact that there is no one
department or agency with responsibility for their prevention. Injuries can
be viewed as non-medical because prevention involves law enforcement
and physical and social engineering measures rather than medical
treatment. This may lead to a perception that they do not come under the
remit of the health-care system. However, because treatment and
rehabilitation of injuries entails a large expenditure in the health service,
it is a subject of great importance to the health system.
Epidemiology
The epidemiology of injuries can be influenced by economic, social and
population developments. Technical progress can aid injury prevention
but equally it can change the environment in which we live and work,
making it either more or less hazardous. Economic progress can alter our
lifestyle. It may change the amount of time spent at work and leisure and
also change the type of leisure activities we engage in. Males are at greatest
risk for accidental injury. Most injuries occur in the younger age groups,
with another peak in the elderly. There is also a significant problem in
relation to road traffic accidents among young people and work-related
injuries among the working population.
Morbidity and mortality
In 1998, about 46,000 people received inpatient care for injuries in
Ireland. Women accounted for 36 per cent of the injury admissions. They
took up approximately 209,000 bed days. A major cost was incurred while
they were in hospital. High costs also occurred after discharge, and by
those who did not require admission, in terms of accident and emergency,
outpatient, paramedical, and general practitioner care and rehabilitation. 
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Injuries account for 10.4 per cent of admissions overall but a higher
proportion of admissions in young people are injury related, with 17.8 per
cent of 1-14 year old admissions and 20.2 per cent of 15-24 year old
admissions being due to injury. As only 10 per cent of people attending
hospital with an injury are admitted to hospital, it is estimated that in 1998
over 400,000 people may have attended hospital with injuries. Many more
attended their general practitioner. Information on injuries that do not
result in death or hospital admission is not routinely collected. It is
difficult to obtain a full picture of the epidemiology of non-fatal injuries.
Each year 1,400 people in Ireland die from injuries. The most common
causes of injury deaths (Figure 5.1) are road traffic accidents (31 per cent)
and suicides (31 per cent), followed by falls (14.8 per cent), poisoning (8.2
per cent), and drowning (4.2 per cent). Suicide is an extremely important
area. It has different causal factors and intervention requirements to other
injuries. Suicide will not be discussed further here but will be dealt with in
more detail in a future report. Accidents account for about 4.5 per cent of
deaths overall but they account for 37.7 per cent of deaths in people under
45 years. Males, particularly in their early twenties, are at greater risk of
death from injury than are women. The high death rate from injuries
among males is mainly due to their high rate of death from road traffic
accidents. The latter are the most significant category of fatal accidents
among people under 65 years of age.
5 9I n j u r y
Source: CSO
14.8%  Falls31%  Road Traffic Accidents
10.8%  Other
31%  Suicides
4.2%  Drowning
8.2%  Poisoning
Fig 5.1: Injury Deaths by Principal Causes, Percentage Distribution, 1998
Road traffic accidents (RTAs)
In 1997, 472 people were killed in 424 fatal accidents on Irish roads. This
is a lower number compared to the 1970s when there were between 500
and 600 road deaths per year (Figure 5.2). There has been a steady
increase in the amount of travel on Irish roads over the years and although
the number of accidents has increased the number of deaths has decreased.
This may be the result of protective measures such as better vehicle design,
airbags, and child restraints, or of better medical care and improved
survival following accidents. There is room for improvement in terms of
the trauma response, to ensure that seriously injured patients receive basic
first aid immediately and arrive quickly at the hospital which can most
appropriately cater for their injuries.
The death rates have levelled off in the past few years but the level of minor
injuries continued to rise until the implementation of the Road Safety
Strategy. In 1997, 13,115 persons were injured in 8,072 injury accidents on
Irish roads. Car users make up 63 per cent of casualties, pedestrians 13 per
cent, motor cyclists 9.5 per cent and pedal cyclist road users 5 per cent.
Road traffic accidents are the most significant cause of admission to
hospital in terms of severity of injury. The method by which an individual
is most likely to be injured changes in each age group. Under one year the
child is at risk as a car passenger; in toddlers the risk of a pedestrian
accident increases; and as they get older they become more vulnerable as
cyclists. Motorcycle accidents mainly affect the 15-34 year age group, and
vehicle injuries are most common in the 25-44 year age group.
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Factors influencing the severity of injury sustained include poor interior
crash protection for the occupants and failure to use appropriate restraints.
Wearing restraints reduces the risk of serious injury and death. However,
only about 64 per cent of people wear seatbelts. Usage is higher among
those travelling in the front seat compared to rear seat passengers. In the
SLÁN survey, 74 per cent of females stated that they always wore a seatbelt
in the front seat of a car, compared to 61 per cent of males. The use of
safety restraints by children is even lower. Road traffic accidents have
major cost implications. The National Roads Authority has estimated the
cost of road traffic accidents in 1997 to be £886,000 for fatal injury,
£110,000 serious injury, £10,500 minor injury, and £1,148 for
material damage accidents. This is an underestimate of the true cost as it
does not include injuries that occurred in accidents that were not reported
to the Gardaí. In order to reduce road deaths further it is necessary to
succeed in reducing the number of road accidents occurring.
The elderly
The ageing of the population poses a special challenge in relation to injury
prevention. The elderly have the highest admission rate following injury,
the longest length of hospital stay and the highest need for long stay
accommodation following discharge. In the elderly, falls are the main
source of injury causing death. In 1997, 208 people died as a result of a
fall. Of these, 70 per cent were older than 65 and 58 per cent older than
75 years. Hip fractures following falls are what most frequently lead to
injury admissions and deaths among old people. The risk of falling and the
likelihood of severe injury increases with age. Older people are at
increased risk for a number of reasons including failing vision, reduction
in short-term memory and slower reflexes. Osteoporosis can predispose
older women to hip fractures. Outcomes of hip fracture are poor and
increased dependency following a fall means that they are more likely to
require admission to a nursing home.
In 1997, 16.5 per cent of all those killed in road accidents in Ireland were
aged over 65, although they form only 11.4 per cent of the population.
Older people are also at particular risk from injury or death from domestic
fires. In 1997, 38 per cent of all people killed in fires were aged over 65. In
house fires, deaths occur typically as a result of smoke inhalation and
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burns. The high fatality rate among older people may result from their
reduced likelihood of escaping from house fires and their reduced
likelihood of survival following fire-related injury.
The number of people aged 65 and over in Ireland is increasing. The
largest increase will be seen in people aged 80 and over. There will be a
parallel increase in the number of people in this age group suffering death
and disability from injury, with a consequent cost burden to the health and
social services. Prevention entails ensuring that they have a safe physical
environment to live in and that personal risk factors are minimised. This
includes preventing osteoporosis through lifelong good diet and exercise,
and early adequate management of conditions such as cataract and hearing
loss that may predispose to accidents.
Children
Injuries are the most common cause of death in children. In 1997, 56
children under 14 years died from injuries. Road traffic accidents were the
main cause of injuries leading to death (52 per cent of deaths); 55 per cent
were pedestrians, 34.5 per cent were motor vehicle occupants and 7 per
cent were pedal cyclists.
In 1998, 10,515 children between 1 and 14 years were admitted to hospital
with injuries. The number of children attending GPs and Hospital A+E
departments is not quantified but it is estimated that approximately 20 per
cent of children each year may attend hospital with an injury and 10 per
cent of all children attending with injuries require admission to hospital.
Falls are the main cause of injury requiring admission. Burns and
poisonings, while less common, are important in terms of seriousness and
can lead to high medical costs, suffering and disability. Young children
receive more injuries in the home than anywhere else. There is a social
class gradient for injuries at home, with children from disadvantaged
homes being at greatest risk.  Houses are built for adults rather than for
children. The average home contains many structures and products which
are accessible to children and present a risk of injury.  The provision,
installation and maintenance of home safety devices offer potential for
injury reduction.
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Work-related injuries
In 1998, 70 fatal work-related accidents occurred in Ireland and 6,512
work-related injuries were reported to the Health and Safety Authority.
The majority of deaths occurred in agriculture and forestry (26) and
construction (22) and were caused by falling or by being struck or crushed.
Those working in agriculture are also exposed to environmental hazards,
toxic chemicals and infectious diseases. The hazards extend to the workers’
families and visitors to the farm. It is worrying to note that seven of the
agricultural deaths occurring in 1998 were children, six of which involved
tractors. Deaths in agriculture and forestry had fallen in recent years until
the dramatic increase in 1998. Deaths in the construction industry are
gradually rising. There are concerns at the level of safety provided in the
construction industry. The current level of fines does not act as a sufficient
incentive to provide safe systems of work. There is a need for more active
interventions to encourage safe working environments for our workforce.
Surveillance
In order to develop a comprehensive and effective strategy for injury
prevention there must be the means for determining the epidemiology of
the injuries and for monitoring trends.  This will enable those responsible
to set priorities, plan prevention and generally raise public awareness. It
will also facilitate the evaluation of any preventive measures that are
introduced. Some information is available from sources such as National
Roads Authority (NRA), European Home and Leisure Accident
Surveillance System (EHLASS), Hospital In-Patient Enquiry System
(HIPE), local systems and studies undertaken from time to time. However,
there is little knowledge about the true incidence of non-fatal trauma.
Even where data are recorded, there are concerns regarding the
completeness and accuracy of the data. Circumstances of the accident are
often unknown and the data generally relate to the injury, not to the cause.
There is no single source to provide data on non-fatal injuries and data
tend not to be specific to particular groups or to geographical areas. There
is no infrastructure whereby agencies with information can share it and
develop common parameters that would allow for comparisons and permit
identification of trends.
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It would be useful to develop injury surveillance in selected representative
areas, which would enable a view of the national situation to be estimated,
and improve links between the data that are already available. The Office
for Health Gain is currently undertaking work in this area. Its aim is to
facilitate the provision and use of data in order to enable interested parties
access and utilise information to promote injury prevention measures.
Prevention
There are three main approaches to injury prevention: education,
enforcement and environmental change. The most effective measures
involve product design and environmental modifications but a
combination of all three strategies are usually required. Changes cannot be
achieved by education alone. What is important is to prevent the accident
from occurring and if this is not possible, then the consequences of the
event must be minimised.
Preventive measures include establishing a safe working and living
environment; creating protective devices for individuals such as helmets
and seat belts and early warning systems such as smoke alarms; ensuring
that the emergency services and treatment and rehabilitation services are
of the highest quality.  Advances in trauma care have contributed to the
reduction in injury deaths over the years. It is essential that the injured be
transported to the most appropriate hospital as quickly as possible.
Immediate and effective care of the injured before they reach hospital is
also important in improving the chance of survival and reducing
complications and the risk of disability.  Life-threatening complications
such as airway obstruction can often be prevented by early basic life
support. Consideration should be given to more widespread training in
first aid for parents, for schools and for the workplace.  Since a large
proportion of pre-hospital deaths occur in road traffic accidents, basic first
aid training could be considered as a requirement for those applying for a
driving licence.
Some preventive measures require that individuals be persuaded to take
action to protect themselves or their children, either voluntarily or
through legislation. Other measures are directed at designing products and
environments (sometimes required under legislation) which reduce the
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risk of injury without the need for action on the part of individuals.
Legislative and enforcement methods are usually more effective when the
public accepts that they are necessary.  Educational measures may be used
to prime the population in advance. An example of this may be seen in the
road safety initiatives undertaken in Ireland. It has now become socially
unacceptable to drink and drive in Ireland. Gradually the same will
happen with speeding. In a climate of limited resources, it is often
necessary to make choices about the most cost-effective way to achieve the
best results from an intervention.
Some excellent work is taking place to prevent accidents. It needs to be co-
ordinated and strengthened. It is sometimes difficult to determine where
the responsibility for injury prevention should lie. The health services
have responsibility for the care of the injured and bear the brunt of the
costs incurred. Many other agencies are involved in prevention of injuries
on the road, in the workplace, at school, etc. When there are so many
involved there is a likelihood that there will be duplication of efforts and
that some areas may be overlooked. There is no single agency with the
mandate to co-ordinate the work of all the others involved and to make
sure that nothing is omitted.
Since treating those with injuries is the responsibility of the health-care
system, perhaps the health sector should take a more active role in co-
ordinating efforts at injury control. However, other government
departments have a part to play. The Department of the Environment and
Local Government has the power to produce safe road design and housing.
The Department of Justice, Equality and Law Reform has the power to
enforce legislation for drunk driving and speeding. The Department of
Enterprise, Trade and Employment has the power to regulate unsafe
products. The Department of the Marine and Natural Resources is
responsible for safety at sea. The multifaceted aspect of injury prevention
results in responsibilities being widely diffused. We need to identify a
government body that will give visibility to this problem and develop a co-
ordinated approach to address it. The health sector, as an advocate for
health, must become more actively involved in working with the relevant
departments and agencies, to quantify the extent of the problem, determine
the research needed and develop policy and preventive measures.
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Current progress
The Office for Health Gain was established in Ireland to facilitate the joint
working by health boards to achieve measurable health gain. Injuries were
chosen by the Office for Health Gain as a key area which requires
investigation. It also established the National Accident Forum in 1996 to
facilitate a co-ordinated approach to injury prevention at national and
regional level. A wide variety of agencies are represented in the Forum. 
The government’s National Road Safety Strategy, 1998, intends to reduce
the level of serious and fatal road traffic injuries by at least 20 per cent by
the year 2002. In 1998, the number of serious injuries fell by 12 per cent
and the number of deaths fell by 3 per cent. While a reduction in deaths is
welcome, it is disappointing that the decline was not greater considering
the enormous effort made by the Gardaí. It is essential that the Gardaí be
given the resources and public support necessary to carry out this work.
Experience in Australia shows that investment in enforcement and
advertising can result in major savings in rehabilitation costs and
insurance claims. A recent report commissioned by the National Safety
Council estimates that the economic benefit of achieving the targets set by
the government’s National Road Safety Strategy will be at least £536m in
the period 1998 to 2002. In addition to the requirement for sufficient
resources, the success of the strategy will depend on public ownership of
road safety and acceptance by individuals of their own responsibility to
contribute to the safety initiative.
Conclusions
Injuries continue to occur at an unacceptable level in Ireland. In addition
to the human costs there are heavy financial costs to the health services,
which if they could be reduced would make more resources available to meet
other priority needs. While many groups are undertaking excellent work in
an effort to reduce the burden of injury, they face numerous difficulties.
There is a need to establish mechanisms for effective co-ordination of
activities, improve the information base, and invest in action that will
provide an environment in which people can live and work in safety.
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Communicable
diseases have always been
recognised as a major threat to
public health. In the nineteenth and early
twentieth centuries, major health problems were
associated with poor nutrition, over-crowding and
inadequate water supplies. These conditions led to a high
incidence of tuberculosis, gastro-enteritis, respiratory
diseases and infant mortality. At the turn of this century, the
Spanish flu ravaged continents and killed more than 20
million people in a few months. 
In recent years, improved economic and social conditions,
together with public health action, have virtually eliminated
the pandemics of communicable diseases. Medical
advances, including the development of vaccines and
new drugs, the provision of safe drinking water,
better nutrition and improved personal hygiene,
have reduced the threat of infectious
diseases to the population.
Communicable
Diseases 6
The worldwide eradication of small pox represents one of the most
significant medical achievements of all time. Poliomyelitis is now targeted
by the World Health Organisation for global eradication.
More recently, however, infectious diseases which were well controlled
have begun to reappear and are reaching epidemic proportions in some
countries. A combination of factors, including the slackening of
vaccination programmes, poor living conditions, anti-microbial resistance
and scarce health-care resources, have contributed to the resurgence of
these infections. Within countries, there is evidence that communicable
diseases are associated with socio-economic deprivation. Worldwide,
infectious diseases remain a major cause of mortality, accounting for
approximately 17 million deaths annually in developing countries and
500,000 in the industrialised world. In developing countries, they
represent more than 70 per cent of the global burden of disease and in
industrialised countries are a major cause of school and work
absenteeisms. When infectious diseases are not adequately controlled, they
can place a tremendous burden on economies. The World Health
Organisation considers that the benefits of controlling or eliminating
infectious diseases far outweigh the costs incurred.
In Ireland, we have come a long way since the poliomyelitis and
tuberculosis epidemics which affected thousands of people and resulted in
significant morbidity and mortality in the 1950s. In the 1990s, public
expectations are high and communicable diseases are often perceived to be
a problem of the past. New threats have emerged, however, in the form of
AIDS, BSE and CJD, hepatitis and E.Coli. This underscores the likelihood
that infectious diseases will remain a significant problem, even in
developed countries, for many years to come. The full impact of these
infections on the human population has yet to be determined. The main
challenges for the future will be to contain communicable diseases at their
current low levels and also to limit the emergence of new infections. It is
also important to gain a greater understanding of anti-microbial resistance
and develop strategies to contain the spread of this problem.
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Trends in communicable disease
Over the past 50 years, there has been a marked change in the pattern of
communicable diseases in Ireland. In 1947, when the Department of
Health was established, there was considerable mortality from infectious
diseases which included not only tuberculosis but also conditions such as
typhoid fever, scarlet fever, whooping cough, diphtheria, influenza, polio
and measles. In children aged between 1 and 5 years, the vast majority of
deaths were caused by infectious diseases including pneumonia,
tuberculosis, whooping cough, measles, gastro-enteritis and diphtheria. In
older children aged between 5 and 15 years, the most common cause of
death was tuberculosis. Tuberculosis was also the major cause of death
among adolescents and young adults under 45 years of age. In recent
years, tuberculosis has diminished in frequency. However, it remains a
problem because of the issue of antibiotic resistance and its association
with the HIV/AIDS epidemic.
Immunisation
In Ireland, the benefits of childhood vaccinations are clear. Immunisation
has had a dramatic impact on the incidence of many communicable
diseases, with a corresponding reduction in mortality. The overall aim of
the National Childhood Immunisation Programme is to eliminate vaccine-
preventable diseases including diphtheria, pertussis, tetanus, polio,
haemohilus influenzae type B, measles, mumps and rubella, by achieving
at least a 95 per cent vaccine uptake in the childhood population. The
Department of Health and Children monitors the incidence of infectious
disease through the notifiable disease reporting system and this
information is supplemented by surveys in the community and laboratory
settings. The changing patterns of communicable disease, together with
the availability of new vaccines, indicate the necessity of continuing to
review our immunisation programmes. The Department acknowledges the
important role played by the Immunisation Advisory Committee of the
Royal College of Physicians of Ireland in the formulation of policy advice
in this area. The publication of new guidelines in relation to primary
childhood vaccination is welcome.
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Vaccine safety
Vaccines are amongst the most effective public health measures that are
available. The incidence of vaccine-preventable diseases, together with
their associated complications, has greatly declined in Ireland. Many of
these infections are now at a level where we tend to forget the seriousness
of these conditions. Instead the focus has shifted onto vaccine safety.
Recent ‘vaccine scares’, including Hepatitis B vaccine and MMR, have been
widely reported in the media. Claims are sometimes made with little
concern for the potential harm resulting from loss of public confidence in
the vaccine and the consequent decrease in the number of children
vaccinated. Follow-up studies which do not collaborate these claims rarely
achieve similar publicity. The international consensus, including that of
the World Health Organisation, is that these are safe and effective vaccines.
The Irish Medicines Board (IMB) is responsible for the monitoring and
safety of all pharmaceutical products sold in Ireland. The monitoring of
vaccine safety is ensured through clinical trials prior to licence and post-
licence surveillance by the IMB. The overall aim of the National Childhood
Immunisation Programme is to eliminate vaccine-preventable diseases by
achieving at least a 95 per cent vaccine uptake rate. If uptake declines,
there will be a resurgence of these infections as was demonstrated by the
recent diphtheria and polio outbreaks in Europe. The policy of the
Department of Health and Children is to promote vaccination based on
Irish and international scientific advice which concludes that the benefits
far outstrip possible risks. Adverse reactions do sometimes occur but most
of these are minor and transient. Immunisation offers the possibility of
eliminating a number of serious infections in the Irish population.
However, this is contingent on a high uptake of vaccination. The challenge
for the twenty-first century is to use these vaccines effectively and, where
appropriate, to incorporate new and safe vaccines into the national
programme.
Measles, mumps and rubella
The impact of measles vaccine is apparent from Figure 6.1. Prior to the
introduction of the measles vaccine in 1983, there were almost 10,000
cases per year in Ireland. This resulted in significant morbidity for Irish
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children. The incidence has dropped in recent years, apart from an
epidemic in 1993.
The World Health Organisation has targeted that indigenous measles be
eliminated from the European region by the year 2007. In contrast with
many other European countries, Ireland has been unable to clear this
residual measles infection, primarily because of inadequate immunisation
coverage. National MMR vaccine coverage is approximately 80 per cent.
This falls short of the target of 95 per cent uptake rate in the childhood
population. Measles elimination will result in substantial health-care cost
savings. The goal of elimination will require strengthening of our
surveillance system, together with improved immunisation coverage in the
childhood population.
The incidence of mumps and rubella remains unchanged in recent years.
Mumps is less infectious than measles. However, some children require a
second dose for protection against this infection. Rubella is a mild
infectious disease, but its occurrence in pregnancy can result in major
damage to the child, including mental handicap, visual and hearing
problems and congenital heart disease. The primary aim of the health
sector is to eliminate the congenital rubella syndrome by protecting
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Fig 6.1: Measles, Mumps, Rubella, Whooping Cough Notifications
women of childbearing age and secondly to interrupt the transmission of
rubella infection in young children. These issues spell out the importance
of providing adequate protection against measles, mumps and rubella in
early childhood. This may require a catch-up programme in some school
children who have not received the second dose of the MMR vaccine.
Diphtheria, pertussis, tetanus and polio
There have been no recorded cases of diphtheria in Ireland for many years
and the WHO target has been achieved. However, the diphtheria epidemic
that occurred in the former Soviet Union countries in the beginning of the
1990s demonstrates the need for ongoing primary and booster
immunisations by use of the currently available combination vaccines.
Pertussis (whooping cough) is a highly infectious bacterial disease which
may cause periodic outbreaks. It can result in significant morbidity and
may be complicated by pneumonia, seizures and brain damage. The recent
introduction of the acellular pertussis vaccine reduces the possibility of
adverse reactions and has improved vaccine uptake to almost 85 per cent
of the childhood population. The full course of vaccine confers protection
in over 80 per cent of children. It is very important, therefore, that vaccine
uptake targets are achieved so as to reduce the incidence of this infection.
The ongoing monitoring of pertussis infection will determine whether
changes are necessary in the vaccine schedule.
In Ireland, tetanus is a rare disease. Nevertheless, the organism exists
widely in the environment. Immunisation is provided as part of the
primary childhood immunisation programme. Booster doses are necessary
to provide protection in later life. The introduction of a combined tetanus
toxoid/low-dose diphtheria toxoid at school-leaving age should confer
additional immunity against these infections.
Poliomyelitis infection is endemic in some developing countries and in
Europe has been targeted for elimination by the World Health
Organisation. The process of certifying poliomyelitis has commenced in
Ireland. This strategy entails high routine immunisation coverage,
together with enhanced surveillance. Live oral polio vaccine is used for
routine immunisation and inactivated polio vaccine is also recommended
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for certain clinical conditions. The ongoing surveillance of both polio
disease and potential adverse reactions to the vaccine will influence future
immunisation policy.
Viral hepatitis
Hepatitis A 
Hepatitis A virus is usually benign. However, in some cases it may cause
serious liver disease. The incidence of hepatitis A follows a cyclical pattern
(Figure 6.2). In Ireland, most cases are caused by person-to-person
transmission and are sporadic. Outbreaks do occur and illustrate the need
for good standards of hygiene and immunisation where appropriate.
Hepatitis B
Worldwide, hepatitis B is a highly endemic viral infection which may cause
hepatitis, cirrhosis of the liver and liver cancer. The incidence of hepatitis B
infection varies throughout Europe and is highest in the Mediterranean and
Eastern European countries. Ireland has one of the lowest prevalence rates
of hepatitis B infection in Europe. Approximately one in 4,000 (0.026 per
cent) of new blood donors tested positive for HBsAg in recent years. While
the incidence of hepatitis B infection has reduced since the mid-1980s, it
has, however, increased slightly in recent years (Figure 6.3). It is also
apparent that there is under-reporting of hepatitis B when laboratory
confirmed cases are compared with statutory notifications.
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Fig 6.2: Hepatitis A Notifications
In Ireland, immunisation is recommended for individuals who are at
increased risk of hepatitis B infection because of their occupation, lifestyle
or close contact with a carrier of hepatitis B. A high compliance amongst
the targeted populations is crucial if this approach is to be successful. The
early detection and management of hepatitis B in pregnancy and the new-
born is also important and should be included in the ante-natal programme.
There are a number of ongoing epidemiological studies on hepatitis B
which will provide additional information regarding the distribution of this
infection. This information, together with the evaluation of the targeted
immunisation programme, will influence the nature of future strategies for
the long-term control of hepatitis B in Ireland.
Influenza
Influenza is a highly infectious viral infection which results in significant
morbidity amongst the population. Influenza activity peaks in the winter
months and localised outbreaks occur at variable intervals. The
immunisation programme is primarily directed at individuals who are at
increased risk of influenza-related complications. In 1998, the target group
included adults older than 65 years. This produced a welcome reduction
in the morbidity from influenza. It is important to improve our public health
and laboratory surveillance of influenza which, together with the WHO and
the EU Communicable Disease Network, will provide early warning in
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relation to major outbreaks of influenza in the coming years. Finally, it has
been approximately 20 years since the last pandemic and it is therefore
important to refine the national contingency plans for this situation.
Meningococcal disease
Meningococcal disease is a serious condition with high morbidity and
significant mortality. The frequency of this infection has increased in recent
years (Figure 6.4). The prevention of meningococcal infection has been
greatly facilitated by the development of the Meningococcal Reference
Laboratory at the Children’s Hospital, Temple Street, which provides
comprehensive epidemiological laboratory information on a national basis.
The Department of Health and Children’s Working Group on Bacterial
Meningitis and Related Conditions monitors the epidemiology of
meningococcal disease and makes recommendations in relation to its
prevention. The Group’s second report, published in 1999, included
guidelines for the hospital management of suspected meningococcal
sepsis/meningitis. A new conjugate vaccine against Group C meningococcal
infection will soon be available and it is recommended for everyone under
22 years of age. The National Working Group will also monitor the
development of vaccines against Group B meningococcal infection.
Pneumococcus
Pneumococcal infection is a significant cause of mortality in vulnerable
groups. In recent years, antibiotic resistance has emerged and is a cause of
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Fig 6.4: Bacterial Meningitis Notifications
concern. Vaccination is now available for at risk groups and adults older
than 65 years of age. The impact of the pneumococcal vaccine will require
evaluation as will new developments, including the emergence of a
conjugate vaccine.
Tuberculosis
The incidence of tuberculosis has declined since the 1950s. However, it
remains a public health threat in view of the nature of the infection (Figure
6.5). In 1996, the Department of Health and Children published the report
of the Working Group on Tuberculosis which outlined a model for the
prevention, diagnosis and management of tuberculosis in Ireland. Core
concepts included the early identification and appropriate treatment of
tuberculosis cases and the screening and follow-up of close contacts. The
key to eradication of tuberculosis in this country is an active surveillance
system, with prompt notification, early treatment and thorough contact
tracing of all cases of tuberculosis.
The range of information available from the surveillance system has now
been expanded and new case definitions which align with WHO policy
have been developed. The operation of the surveillance system will be
devolved to the newly-established National Disease Surveillance Centre
(NDSC).
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Fig 6.5: Tuberculosis Notifications
The development of a National TB Reference Laboratory facility is
considered to be an important element of the surveillance strategy.
Although multi-drug resistant TB is uncommon in Ireland, it is increasingly
recognised in Europe. This underlines the importance of good public health
and laboratory surveillance of TB.
BCG vaccine is available for the prevention of TB and is most effective
against TB meningitis and miliary tuberculosis. It has been generally
recommended that BCG vaccine be administered to infants in the neonatal
period. It is also recognised, however, that BCG policy was not
standardised across all health board areas. The most recent TB surveillance
data indicate that the incidence of TB has reduced in most areas including
those where BCG is not administered in the neonatal period. Ireland is
approaching the level of TB infection where the discontinuation of BCG
vaccination may be considered. The provision of additional surveillance
data, including clinical outcomes, will influence future policy.
The National Tuberculosis Advisory Committee is liaising with the
Regional TB Committees with respect to all aspects of tuberculosis control
throughout the country. Considerable progress has been made. However,
it is very important to monitor trends in incidence and to be alert for the
emergence of multi-drug resistant TB.
HIV/AIDS
In 1992 the Department of Health and Children published a National AIDS
Strategy which was aimed at reducing the number of people who
contracted HIV infection and providing the best possible treatment and
care for those who were HIV positive or had developed AIDS. The National
AIDS Strategy Committee (NASC) continues to advise the Minister and
the Department on HIV and AIDS policy.
Additional surveillance information demonstrates the emergence of new
trends (Figure 6.6). More than 2,000 people have tested positive for HIV
in Ireland. Of these, approximately two-thirds were male. The major
exposure categories over the past seven years have been injecting drug use
(32 per cent), homosexual exposure (28 per cent), and heterosexual
exposure (21 per cent). There has been an increase in heterosexual
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transmission over the past three years and in 1998 this was the most
common means of transmission of the HIV virus in Ireland.
The incidence of AIDS in Ireland has declined, similar to the pattern in
other developed countries. At the end of the second quarter of 1999, 682
cases of AIDS and 344 deaths were recorded. The major categories were
intravenous drug use followed by homosexual/bisexual transmission. The
use of highly active anti-retroviral treatments has retarded the
development of AIDS and reduced mortality from this infection.
The new HIV/AIDS strategy will focus on surveillance, prevention and
education, care of persons infected with HIV/AIDS and anti-
discrimination. The paradigm of ‘integrating prevention with cure’ will be
central to future planning. The provision of more clinics and new
programmes for drug misusers, together with additional services for the
gay community and ongoing support for the voluntary agencies, will form
the basis of the prevention programme.
Education and information on HIV/AIDS will continue through the use of
media campaigns and the publication of resource material for effective
HIV/AIDS education. The care and management of persons infected with
HIV/AIDS has been improved through additional consultant appointments
including those with expertise in palliative care. Anti-retroviral therapy
has significantly improved the management of this infection. However,
there will be additional diagnostic requirements such as viral load
measurement and the monitoring of anti-viral drug resistance.
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Fig 6.6: AIDS/HIV Incidence
In the area of HIV/AIDS surveillance, the anonymous unlinked HIV
screening of antenatal bloods highlighted perinatal transmission of HIV as
an important issue. The first five years of this programme resulted in 64
cases being confirmed HIV positive. Routine linked antenatal HIV testing
has been introduced during 1999. Antenatal screening and treatment of
HIV positive women, together with careful management of the delivery,
can reduce the chance of infection in the baby by approximately two
thirds. This programme will be evaluated on an ongoing basis and, for the
time being, anonymous testing will continue.
The surveillance of HIV/AIDS is undergoing change. It is increasingly
recognised that a system of case-based HIV surveillance, similar to the
AIDS surveillance system, would provide better information on the
transmission of HIV infection and on the factors that are associated with
clinical outcome. The development of such a system should adhere to the
appropriate safeguards for privacy and patient confidentiality. 
Gastroenteric pathogens
Food-borne and water-borne diseases are increasingly recognised as a
significant public health problem. Increased awareness, more intensive
investigation and better reporting have contributed to the increased
incidence of these infections (Figure 6.7). Water-borne diseases, including
giardia and cryptosporidium, have also been recorded. The Food Safety
Authority of Ireland is developing strategies to control food-borne
infections. The recent report on the prevention of E.Coli 0157:H7
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Fig 6.7: Food Poisoning/Salmonella Notifications
infection contains a number of practical recommendations to prevent
human cases of this disease.
It is recognised that more sophisticated typing in reference laboratories is
required to enable earlier identification of outbreaks. It is also important
to electronically transfer this information from laboratories to the public
health department of health boards and the National Disease Surveillance
Centre. It will be necessary to review the infectious disease regulations
(1981) to take account of the emergence of these infections as a public
health problem.
Transmissible spongiform encaphalopathies
Creutzfeldt-Jakob disease is a rare, fatal human neurological condition that
occurs worldwide. Sporadic CJD is by far the most common subtype and
its cause remains unknown. vCJD was first described in March 1996 and
is linked with exposure to the Bovine Spongiform Encephalopathy (BSE)
agent that affects cattle.
In Ireland, the Department of Health and Children has established an
advisory committee which makes recommendations in relation to the
prevention of transmission of CJD. This Committee works closely with the
Department of Agriculture and Food which has responsibility for the
control of TSE in the animal population. Over the past three years, a
variety of issues have emerged which have necessitated a rapid public
health response. As vCJD is relatively new and there is much to learn about
the condition, the nature of this response has been based on the
precautionary principle. In particular, there is a requirement for further
work on risk assessment and management which would guide decision-
making in the future.
Anti-microbial resistance
Bacteria and other micro-organisms have demonstrated resistance to anti-
microbials for many years. However, recent evidence indicates a significant
increase in the prevalence of drug resistance among bacteria. This
development has paralleled the expansion of anti-microbial use in the
human and animal populations. Some bacterial species are now able to
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develop resistance to the majority of therapeutic agents. The issue is now
a major European and global health problem because of serious
implications for the treatment and prevention of infectious diseases in the
human and animal populations. Anti-microbial resistance and its various
causes will require a multi-disciplinary and cross-sectoral approach. 
In Ireland, there is little systematic information regarding the prudent use
of anti-microbials. The EU has initiated a limited anti-microbial resistance
surveillance project in which Ireland participates. There is a need to
extend such surveillance in humans, animals and food stuffs. It is also
important to monitor and control the usage of antibiotics in clinical
practice and to adhere to the principles of infection control both in
hospital and community settings. The Department will work towards
establishing multi-disciplinary and cross-sectoral policies to reduce the
level of antibiotic resistance in Ireland. 
Emerging issues
Isolation facilities
The suspected outbreak of viral haemorrhagic fever in Germany during
August of 1999 has highlighted the need to provide appropriate isolation
facilities for acute infectious diseases. Such facilities should provide for
intensive care support for childhood and adult populations. It is also
considered important to provide laboratory support which has the
appropriate containment level facilities.
New vaccines
A range of vaccines is becoming available including the pneumococcal
conjugate vaccine, new combination vaccines and vaccines against
rotavirus and varicella. In the longer term, future candidate vaccines that
protect against hepatitis C, herpes simplex, respiratory syncitial virus and
HIV may become available. Vaccine developments in this area will be
monitored and introduced as appropriate so as to reduce the public health
threat from these infections.
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Enhanced surveillance
The recently established National Disease Surveillance Centre (NDSC) is
expected to play an increasingly important role in the surveillance and
outbreak management of communicable diseases. The NDSC will act as a
resource for the health boards and, in addition, will take on the national
operational aspects of surveillance which were previously performed by
the Department of Health and Children. Together with the Department of
Health and Children, it will provide the Irish input into the EU Network
of Communicable Disease Surveillance and Early Warning Response
System. These new operational changes will require legislation to establish
the NDSC on a statutory basis. Legislative change will also be necessary to
amend the list of notifiable diseases and the reporting system requirements.
Conclusions
Although communicable diseases are no longer responsible for the high
levels of morbidity and mortality of previous years, they remain a cause of
concern. The re-emergence of TB and diphtheria in Eastern Europe
indicates the consequences of a slackening in effort in this area. The
emergence of diseases including vCJD, HIV and E.Coli 0157 highlight the
need for continued vigilance and the development of appropriate strategies
to minimise such threats to public health.
The prerequisites for success in the control of communicable disease
include well-defined strategies based on public health and laboratory-
based surveillance and the provision of adequate resources to strengthen
the infrastructure that underpins the control of communicable diseases.
New opportunities are becoming available including novel vaccines and
enhanced information technology. The challenges for the future are to
exploit these opportunities and to develop them into appropriate strategies
that reduce the burden of communicable diseases in Ireland.
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The health of the Irish
population has improved significantly
over the past 50 years when measured by
indicators such as life expectancy, and infant,
perinatal and maternal mortality.
This has been mainly due to the control and, in some
cases, the elimination of potentially lethal infectious
diseases such as TB, polio and diphtheria. Despite these
successes, vigilance must be maintained. Strategies must
be in place to prepare an effective response against the
threat of new infectious diseases, the re-emergence of
diseases, and the problem of anti-microbial resistance.
Premature death from chronic diseases such as cancer
and cardiovascular disease is higher in this country
than in other European countries. Interventions
against these diseases represent a
significant challenge for the years
ahead. 
Conclusions
This will require moving these issues into a broader, multi-sectoral policy
context as regards their prevention and, within the health sector,
concentrating on the achievement of measurable health and social gain by
ensuring the greater utilisation of effective evidence-based interventions.
Finally, there is a need to reduce the burden of excess mortality and
morbidity suffered by the poor. Commitment to the identification and
alleviation of health inequalities must be at the centre of our strategic
plans in the coming years. This approach, together with the general
investment in health and preventive services, will enhance the health and
social gain of the population, and this in turn will help maintain our
economic prosperity.
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